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Chapter 1 
 
INTRODUCTION AND RESEARCH QUESTIONS 
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General Introduction 
Pain as defined by the International Association for the study of Pain (IASP) is “an 
unpleasant sensory & emotional experience associated with actual or potential 
tissue damage or described in terms of tissue damage”.1 A more recent (2015) 
definition of chronic pain is given by Treede et al: “Pain is a distressing experience 
associated with actual or potential tissue damage with sensory, emotional, 
cognitive and social components. Usually pain is regarded as chronic when it lasts 
or recurs for more than 3 to 6 months”.2 Chronic pain has a worldwide prevalence 
of 20 to 40%.3,4 Chronic pain patients not only experience severe problems with 
sleeping, functioning and quality of life but also suffer from depression.5 Chronic 
pain is not only an unpleasant sensation but also results in sick leave and is 
accompanied by considerable direct and indirect costs.6 
In a worldwide study by Vos et al, back and neck pain dominated the “Top ten 
causes of years lived with disability” for almost every high income nation.7 This is 
also the situation in the Netherlands, where chronic low back, shoulder and neck 
pain and osteoarthritis of the knee have the greatest prevalence.8 According to the 
American Association of Pain Medicine, more Americans suffer from chronic pain 
than of diabetes, heart disease and cancer combined.9 Even though chronic pain is 
a serious medical and socioeconomic problem, and can be considered as disease 
in its own right, no governmental health institutions and scientific societies consider 
chronic pain or pain in general as a high impact disease.6 Epidemiological research 
helps to raise awareness of the extensive problems associated with chronic pain 
and can direct future research areas to improve pain medicine. For example, 
Bekkering et al. mentioned that increasing accessibility to adequate treatment for 
all chronic pain sufferers should reduce the negative consequences of it on 
individual and public health level and, therefore, chronic pain deserves to get more 
attention from Dutch healthcare workers and policy makers.10 
 
The practice of pain management in the cervical region and the head  
Ideally, adequate treatment of pain in the cervical region and the head only can be 
offered after a comprehensive medical analysis, consisting of medical history 
taking, physical examination and, if indicated, complementary diagnostic testing 
resulting in a medical hypothesis and consequently in an appropriate differential 
diagnosis.6 Besides detailed medical history taking regarding pain characteristics 
and the impact of pain on different domains (e.g. physical, psychosocial, function, 
work, related complaints and comorbidities), other factors such as concomitant 
symptoms, psychiatric history, previous drug dependency, drug use, previous pain 
assessments or (the effect of) previous treatments, complemented by a physical 
examination with focus on neurological and musculoskeletal tests should be taken 
into account. Additional diagnostics consists of MRI, electrophysiological 
examination and e.g. a segmental selective diagnostic blockade. 
Besides the distinction between acute and chronic pain several other 
characteristics can classify pain during history and physical examination. Most 
importantly: (1) the exact location (e.g. which cervical level or what region of the 
head), (2) specific characteristics (somatic, visceral, referenced pain), (3) the origin 
of pain (e.g. oncological) and (4) underlying pathophysiology (nociceptive versus 
neuropathic and mixed). Understanding the origin and characteristics of pain will 
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help to make a patient centered treatment proposal that fits on patients’ needs and 
wishes. Determining which pain category is present can help with specifying the 
treatment plan. One must however remember that pain often is multifactorial. The 
following four categories of chronic pain can be distinguished, namely: (1) 
Neuropathic pain, both peripherally and centrally; (2) Musculoskeletal pain e.g. 
cervical pain or myofascial pain; (3) Inflammatory pain (arthritis, infection), and: (4) 
Mechanical/ compression pain (e.g. visceral pain by tumor pressure).10 In the 
interventional pain practice of cervical pain one can find two kinds of vertebral 
related pain: one with mechanical and one with neurological causes. In the 
category of mechanic pain there are for example facet syndrome, discogenic pain, 
atlantoaxial (AA) joint pain, cervical-related neck pain (Whiplash Associated 
Disorders = WAD).11 From the neurologic causes there are for example Hernia 
Nucleus Pulposus, irritation of the cervical peripheral nerve or pathology of the 
dorsal root ganglion (DRG). One can distinguish two types of pain based on their 
pathophysiology: nociceptive pain (an appropriate physiological response to a 
painful stimulus) and neuropathic pain (an inadequate response caused by 
dysfunction of a part of the nervous system). These two types of pain can occur 
simultaneously in various disorders and are then referred to as ‘mixed’ pain. The 
current management of chronic pain in the cervical region consists of conservative 
and interventional treatment. Both are mentioned further in this thesis, with special 
attention for cervical discogenic pain treated with e.g. percutaneous nucleoplasty12, 
for cervicogenic pain, headaches and WAD with for example percutaneous 
radiofrequency/pulsed radiofrequency (RF/PRF) of the facet joint (zygapophyseal), 
of the AA joint13, for cervical disc hernia with PRF of cervical DRG and for facial 
pain as Trigeminal Neuralgia with RF/PRF of ganglion of gasser.14 
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Table 1, Treatment possibilities for chronic pain in the cervical region 
Conservative  
 
- Physiotherapy 
- Trans Electric Nerve 
Stimulation 
- Manual medicine 
- Neurofeedback 
 
Advice: Repeat treatment 
if patient responds well 
Pharmacological  
 
- Non-steroidal anti-
inflammatory agents 
Advice: Cox-2 inhibitors 
are preferred above Cox-1 
due to less side effects 
- Tricyclic 
antidepressants 
- Anti neuropathica 
- Anti epileptica 
- Benzodiazepines 
- Carbamazepine 
- Oxacarbamazepine 
- Opiates 
Advice: With attendance of 
neuropathic pain the 
combination of three 
medications can be 
considered, (Anti 
consulvants, Anti 
Depressiva and Opiates). 
Interventional - Epidural 
corticosteroid 
administration 
Advice: Epidural treatment 
only for subacute HNP 
- (Pulsed) 
radiofrequency 
treatment 
- Percutaneous 
Cervical 
Nucleoplasty 
- Surgery 
Advice: RF lesion for facet 
pain. PRF for DRG of the 
AA joint. For PCN the disc 
height should be 50% of 
normal and should not be 
used in case of a ‘black 
disc’. 
 
In clinical practice, multidisciplinary rehabilitation with behavioral therapy is 
recommended.  
 
The principle of epidural administration of corticosteroids is based on the anti-
inflammatory effect by inhibition of the phospholipase A2-arachidonic acid 
cascade-initiated. There are several approaches: the interlaminar and 
transforaminal way, but at the cervical level no direct comparative outcome studies 
are published. There is evidence for pain relief after interlaminar administration but 
the transforaminal administration was more commonly used because of the more 
precise delivery at the level of the inflamed nerve root.15 However, several cases 
with serious neurological complications using the transforaminal route, some with 
fatal outcome, are reported in literature.16,17 Based on these findings there is now 
more support for the interlaminar route.18 A stepped care approach (Table 1) for 
the treatment of cervical pain is commonly used with surgery only indicated for the 
most severe and therapy resistant cases if a neurological deficit is present resulting 
in motor dysfunction. 
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Minimally invasive techniques for treating head and neck pain 
The extensive observational descriptions of the positive effects of Radiofrequency 
(RF) treatment in clinical diagnosis of chronic degenerative cervical facet pain 
resulted in percutaneous facet denervation (PFD) being an accepted treatment 
option. RF is nowadays still applied for various pain conditions such as tumor pain, 
nerve pain including trigeminal neuralgia and soft tissue stenosis.19-21 Afterwards 
Pulsed Radiofrequency (PRF) treatment was discovered for different indications 
such as radicular pain, trigeminal neuralgia (TN), occipital neuralgia, shoulder and 
knee pain.22 The first PRF procedure on a lumbar dorsal root ganglion was done in 
1996.23-25 Following this experience many kinds of chronic pain were treated 
successfully with PRF, including cervicobrachial pain, facial pain including 
trigeminal neuralgia (TN), sacroiliac joint pain, facet pain, shoulder pain, 
postsurgical pain, radicular pain, groin pain and myofascial pain conditions.26  
 
Specific techniques for cervical radicular pain 
 
Percutaneous Cervical Nucleoplasty 
Cervical discogenic pain is often caused by cervical disc pathology and hence 
results in suffering and disability in the adult population.27 In general it is a difficult 
and costly health care issue.28 Approximately 1 person in 1,000 suffers from 
cervical radicular pain.29,30 Treatment options range from conservative to surgical 
interventions.31 Pain management for cervical disc herniation relies initially on 
conservative care (rest, physiotherapy, and oral medications). Once conservative 
treatment has failed, different percutaneous minimally invasive (radiological) 
procedures can be applied to relief pain.27 These procedures mainly aim at 
relieving compression or chemical irritation on sensory structures while minimizing 
trauma to normal tissues and enhancing patient recovery.32,33 Although many 
treatment modalities are described in the literature, the available evidence for 
efficacy is not sufficient to allow definitive conclusions on the optimal therapy to be 
made.29,31 The basic principle of most percutaneous procedures is that a small 
reduction of volume in a hydraulic space, like an intact disc, results in a 
disproportionately large fall in pressure. Removal of approximately 1 mL of disc 
tissue volume, corresponds to a discal volume reduction of about 10-20%33,34 
resulting in a relief of some chemical and mechanical factors causing pain.27 While 
the basic mechanism of percutaneous disc decompression (PDD) has been well 
understood, each method has its own limitations like removal of too much tissue, 
indiscriminate removal of tissue, thermal injury to the disc or aggressive access 
into the disc.35,36 A variety of published studies have demonstrated percutaneous 
cervical nucleoplasty (PCN) to be both safe and effective in experienced 
hands.27,32,35-37 PCN is the most often applied technique on the cervical level with a 
low risk of thermal damage.27 
  
Pulsed radiofrequency of the dorsal root ganglion  
PRF of the dorsal root ganglion is well known pain treatment modality and is used 
as a non- or minimally neuromodulatory technique, and full alternative to 
radiofrequency heat lesions which can be neuro-ablative.12 The application of pulsed 
radiofrequency shows a significant reduction in complications or side effects 
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compared to radiofrequency techniques.38 PRF treatment is also indicated at the 
spinal ganglion for chronic cervical radicular pain.39,40 More recent studies showed 
that PRF procedures are probably more effective than conventional radiofrequency 
in the treatment of chronic pain.41,42 Besides being more effective, PRF has also a 
significant reduction in complications or side effects compared to conventional 
radiofrequency.43 This opened the possibility to apply PRF treatment for peripheral 
neuropathies, arthrogenic pain, painful trigger points and neuropathy or 
radiculopathy by application in dorsal root ganglion.44 Both techniques are applied in 
clinical practice with promising results, however evidence for the effectiveness of 
these interventions is not yet well documented.32 There is a need for more high-
quality RCTs investigating the efficacy and safety of both techniques using validated 
outcome measures.31,36,37 Moreover, cost-effectiveness concerning these treatments 
of cervical discogenic pain should be analyzed.  
 
Surgical treatment  
Surgery is indicated for cervical radiculopathy with spinal cord compression and 
possible injury, which if left untreated can lead to progressive and potentially 
irreversible neurological deficits. Surgical treatment may give pain relief in patients 
whose symptoms turn out to be resistant to all other treatments. In a randomized 
study comparing surgical treatment with conservative treatment, three months after 
the intervention a significantly better pain relief with surgery was demonstrated. 
However, one year after surgery, there was no difference between the two 
groups.45 In conclusion, there is no gold standard in the treatment of cervical 
radicular pain. History taking and physical examination are the cornerstones of the 
diagnostic process. Medical imaging, with a preference for MRI, is indicated for 
suspected specific pathology and/or neurological symptoms. 
 
PRF in Trigeminal Neuralgia 
The effectiveness of PRF for the treatment of trigeminus neuralgia was debated in 
several publications.46,47 But in the study by van Zundert et al. and by Yao et al., 
PRF proved to be successful for treating this condition.48,49 Therefore we should 
consider using PRF as an alternative method in trigeminal neuralgia especially in 
patients with anesthesia dolorosa, for very old patients and in doubtful cases, 
taking in account that in our experience over the past years practically no side 
effects of PRF were observed. 
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Aim of the thesis and research questions:  
The aim of this thesis is to investigate the clinical effectiveness and safety of 
minimal invasive interventional techniques in patients with head and neck pain. 
This has led to the following research questions for this thesis: 
1. Is pulsed radiofrequency application of the antero-lateral C1-2 a safe and 
effective technique in patients with cervicogenic headaches who are non-
responsive to conservative treatment such as medication, physiotherapy, 
manipulation, mobilization and to other techniques such as intra-articular 
steroid injections, medial branch of lower cervical blocks and epidural 
injections?  
2. Is there evidence for the use of pulsed radiofrequency application of C1-2 in 
whiplash patients?  
3. Is pulsed radiofrequency treatment also effective in trigeminal neuralgia? 
4. Is percutaneous cervical nucleoplasty for patients with a symptomatic disc 
hernia, a safe and effective method to treat patients? 
5. What is the clinical effectiveness of pulsed radiofrequency compared to 
percutaneous cervical nucleoplasty in cervical disc hernia? 
Outline of this thesis 
In chapter 2 we retrospectively review the effects of lateral C1-2 joint pulsed 
radiofrequency treatment in patients who suffer from cervicogenic headache. In 
chapter 3 we review patients who have whiplash symptoms including cervicogenic 
headache and who are treated with an antero-lateral atlantoaxial joint pulsed 
radiofrequency procedure. In chapter 4 we report the results for a cohort of 
consecutive patients who underwent pulsed radiofrequency treatment for trigeminal 
neuralgia. Chapter 5 describes the long-term efficacy and safety of percutaneous 
cervical nucleoplasty in patients with a contained herniated disc. In chapter 6 we 
systematically review current evidence for percutaneous nucleoplasty as a 
treatment for patients who suffer from a cervical herniated disc. Chapter 7 reports 
on a prospective, randomized controlled trial comparing percutaneous cervical 
nucleoplasty against pulsed radiofrequency of the dorsal root ganglion in patients 
with a contained cervical disc herniation. Chapter 8 summarizes the presented 
study results and synthesizes the conclusions of this thesis, including directions for 
future clinical practice and research. 
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Abstract 
The lateral atlantoaxial joint has long been reported as a source of cervicogenic 
headache. We present a retrospective study, including 86 patients who had 
undergone lateral C1-2 joint pulsed radiofrequency application, for cervicogenic 
headache in a single pain center from March 2007 to December 2008. The 
percentage of patients who had ≥50% pain relief at 2 months, 6 months, and 1 year 
were 50% (43/86), 50% (43/86), and 44.2% (38/86), respectively. Longterm pain 
relief at 6 months and 1 year were predicted reliably by ≥ 50% pain relief at 2 
months (P < 0.001). Apart from 1 patient that complained of increased severity of 
occipital headache lasting several hours, we had no other reported complications. 
Introduction 
The C2 spinal nerve and its dorsal root ganglion have a close proximity to the 
lateral capsule of the atlantoaxial (C1-2) zygapophyseal joint, and its branches 
innervate both the C1-2 and C2-3 zygapophyseal joints. Hence, pathologic, 
inflammatory, and traumatic changes around these joints can be a source of 
referred head pain. The pars caudalis of the spinal nucleus of the trigeminal nerve 
is continuous longitudinally with the outer laminae (laminae I-V) of the dorsal horns 
of the upper 3 to 4 segments of the cervical spinal cord.1,2 This functional 
intersection of upper cervical and trigeminal sensory pathways is believed to allow 
the bidirectional transmission of pain signals between the neck and the trigeminal 
sensory receptive fields of the face and head. This convergence of afferents from 
both the trigeminal nerve and the upper 3 cervical spinal nerves provides for the 
various patterns of referred pain.3–5  
Clinical presentations that are suggestive of pain originating from the lateral C1-2 
joint include: (1) occipital or suboccipital pain, (2) focal tenderness over the 
suboccipital area or over the transverse process of C1, (3) restricted painful 
rotation of C1 on C2, and (4) pain provocation by passive rotation of C1.5 Pain map 
studies have shown that pain distribution patterns are not indicative of its source or 
even the joint responsible.4 At best, these clinical signs have a positive predictive 
value of only 60%.4,5 A major diagnostic criterion is the response to a diagnostic 
intra-articular local anesthetic injection.4,6 Thereafter, an intra-articular steroid 
injection can be considered. However, such intra-articular injections are often 
limited in their duration of efficacy. There has been limited data that lateral C1-2 
joint interventions have long-term efficacy despite their establishment as a possible 
source of pain generation in cervicogenic headaches.5 In fact, much work has been 
initiated to find an alternative for intra-articular steroid injections with a longer 
duration of pain relief.7  
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Even though there is good evidence that the lateral atlantoaxial joint is a source of 
cervicogenic headache,8 to our knowledge, there are currently no published studies 
that have examined the long-term efficacy of lateral atlantoaxial pulsed 
radiofrequency (PRF) application using the anterolateral approach. We now 
describe a retrospective study in 86 patients, many of which had suffered from 
severe headache for more than 10 years in duration. 
Methods 
Institutional research review board approval was obtained prior to the retrospective 
collection of data from all 86 patients. This retrospective study included all 86 
patients who had undergone lateral C1-2 joint PRF application for cervicogenic 
headache, in a single pain center from March 2007 to December 2008. The data 
were collected from the review of patients’ medical records, pain questionnaires, 
and telecommunication verification of details that were not available on the records. 
From the retrospective data, it was found that all patients were predominantly more 
disturbed by the headaches than by their accompanying neck pain. However, apart 
from a predominant unilateral nature of the headache and association with ongoing 
chronic neck pain, a detailed description of the headaches was not available at the 
time of writing this manuscript. All the therapeutic procedures were done by one 
investigator, (W.H.) while the phone verification was done by another assistant with 
no direct involvement in the interventional procedures or the data analysis process.  
The C1-2 PRF application was performed using the intra-articular anterolateral 
approach under fluoroscopic guidance. Patients lie comfortably in a supine 
position, with standard monitors in place, and head in slightly extended position. 
The fluoroscopy C-arm is brought to the head of the table in an anteroposterior 
direction. Under fluoroscopic guidance, the C-arm is rotated in the sagittal plane 
until the lateral atlantoaxial joint is visualized with its characteristic biconcave 
appearance. The C-arm is then given an oblique tilt of about 10 to 20 degrees to 
enhance the imaging of the lateral C1-2 joint as in Figure 1. The needle insertion 
site is marked, and the skin overlying the lateral aspect of the C1-2 joint is prepped 
and draped in the usual sterile fashion. After local anesthetic infiltration of the entry 
point, a 22 G 45mm insulated radiofrequency needle with 5mm active tip is 
advanced in the posteromedial direction. This approach avoids possible contact 
and damage to the C2 nerve root and dorsal root ganglion, which is a possible 
complication from the posterior approach. It is imperative that the lateral C1-2 joint 
is not approached too laterally to avoid veering into the foramen transvasarium, 
which may result in vertebral artery puncture.  
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Figure 1. Oblique view of lateral C1-2 facet joint with needle tip directed toward joint. 
 
 
Bone is often contacted, which allows estimation of depth. The needle is withdrawn 
slightly and directed toward the anteromedial portion of the lateral C1-2 joint. A 
characteristic pop is felt as the joint is entered, usually after advancing only a few 
millimeters. The anteroposterior view (open mouth view) shows the tip of the 
needle in lateral 1/3 of the lateral C1-2 joint as seen in Figure 2. A lateral check 
view shows the tip of the needle in the middle of the joint posterior to the anterior 
margin of the joint. In our center, we do not routinely give contrast to delineate the 
joint and hence we avoid the joint distension pain or discomfort that has been 
described with lateral C1-2 joint injections. It is also for this reason that we do not 
routinely perform diagnostic injections in the lateral C1-2 joint, which in our 
experience can even result in transient ataxia. 
However, prior to PRF application, sensory stimulation at 50 Hz up to 1.0 V 
confirms the intra-articular position of the active tip. Motor stimulation at 2 Hz up to 
1.0 V is expected to be negative. PRF application is then initiated at 45 V, 2 Hz, 
and 10 ms for 10 minutes after positive sensory stimulation.7 No local anesthetic or 
steroid solution is given after the PRF application.  
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All patients were followed up with a telephone consultation after 2 weeks to 
exclude any major complications. Responders were defined as having more than 
50% pain relief after the procedure as per the routine clinical practice in this center. 
All the patients were followed up at 2-month and 6-month intervals in the clinic. 
Patients were also contacted by telephone at the 1-year interval to determine their 
response.  
Data were recorded on a Microsoft® Excel 97 (Microsoft Corporation, Redmond, 
WA). The SPSS version 16.0 Statistical Package (SPSS Inc., Chicago, IL) was 
used to generate frequency tables. The mean, SD, and 95% confidence intervals 
were tabulated. Differences in proportions and means were tested using linear 
regression and results were considered statistically significant if the P value was 
<0.05. 
Results 
Eighty-six patients underwent C1-2 injection from March 1, 2007 to December 31, 
2008. There was no significant difference in the demographics between 
responders and nonresponders. The percentage of patients who had ≥ 50% pain 
relief at 2 months, 6 months, and 1 year were 50% (43/86), 50% (43/86), and 
44.2% (38/86), respectively. Long-term pain relief at 6 months and 1 year were 
predicted reliably by ≥ 50% pain relief at 2 months (P < 0.001). 
As shown in Table 1, the duration of pain before procedure was 9.4 ± 1.1 years 
(mean ± SE), while baseline pain score was 8.5 ± 0.1. Both these variables were 
nonsignificant predictors of ≥ 50% pain relief at 2 months, 6 months, and 1 year (P 
> 0.05). There are 48.8% (42/86) of patients with ongoing insurance claims while 
90.7% (78/86) had undergone a previous nonsurgical procedure for similar 
complaints. Both of these factors were nonsignificant predictors of ≥ 50% pain relief 
at 2 months, 6 months, and 1 year (P > 0.05). Apart from 1 patient that complained 
of increased severity of occipital headache lasting several hours, we had no other 
recorded complications. The limitations of this study are those inherent to 
retrospective studies of such nature where data have been collected in a clinical 
context and, as an example, did not allow us to quantify the reductions in pain 
medications over 1 year of follow-up. 
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Figure 2. Anteroposterior view of lateral C1-2 facet joint with needle tip within lateral 1/3 of joint. 
 
 
Table 1. Demographic Characteristics 
Demographic Characteristics  n = 86 
Gender 
   Male  
   Female 
 
37% (32/86) 
63% (54/86) 
Age (years) 
Mean ± SD 
50 ± 2.1 
Duration of headache (years) 
Mean ± SD 
9.4 ± 1.1 
Visual analog scale before C1-2 pulsed radiofrequency 
Mean ± SD 
8.5 ± 0.1 
History of previous percutaneous interventions  90.7% (78/86) 
Insurance claims  48.8% (42/86) 
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Discussion 
In this retrospective study, we showed that PRF of the C1-2 joint is a feasible 
technique resulting in good outcome in patients with headaches without serious or 
long-term complications in experienced hands. 
In 1998, Sluijter et al. applied high-voltage RF current in bursts of 20 ms per 500 
ms, permitting the generated heat to be washed out during 480 ms “silent phase.” 
This idea of applying high-voltage energy near a nerve without subsequent heat-
induced nerve injury was later termed pulsed radiofrequency (PRF). Since then, it 
has become clear that at tip temperatures below 45°C, neuronal destruction as a 
result of permanent heat-induced ultrastructural damages do not usually occur. 
However, morphological changes such as endoplasmic reticulum cisterns 
enlargement and increase in the numbers of vacuoles are observed under electron 
microscopy after PRF have been reported.9 The mechanism of action of PRF 
application (though not entirely clear) may possibly be via a combination of 
excitatory C-fiber response suppression (as evidenced by the extended duration of 
c-FOS expression) as well as inhibition of synaptic transmission with the decrease 
in excitatory postsynaptic potential.2,10,11 This long-term depression of the first 
synapse, as a result of the generated electric fields within the small joint, most 
likely explains the immediate effects of the lateral C1-2 joint PRF application. In 
addition, intra-articular PRF produces an effect of a more gradual onset that is not 
strictly bound to the strength of the electric field at increased distance from the 
electrode. This could possibly reflect an action of electric fields on immune cells 
that influences the production of anti-inflammatory cytokines. The production of 
proinflammatory cytokines such as interleukin (IL)-1b, tumor necrosis factor a, and 
IL-6 is likely to be attenuated by the generated electric fields.7,12 
The lateral atlantoaxial joints are laterally very narrow and a true lateral approach is 
not feasible. However, when the needle is introduced percutaneously just posterior 
and caudal to the mandibular angle, and directed slightly cranially and posteriorly, it 
can easily be advanced into the wider anterior portion of the lateral joint.13 Such an 
anterolateral approach is believed to reduce the incidence of C2 nerve root injury, 
dura cuff puncture, epidural injection, and vertebral artery puncture. In addition, as 
no local anesthetic or steroid solution is injected, the incidence of ataxia and 
inadvertent vascular injection is minimal. 
In a recent anatomical study, terminal branches of both the superficial and deep 
cervical prevertebral plexus were seen to attach firmly to the lateral C1-2 joint 
capsule. It is most likely that the lateral C1-2 joint receives ventral innervation from 
these nerves. The superficial cervical prevertebral plexus is located deep to the 
longus capitis muscle and ventral to the anterior tubercles of the cervical 
transverse process and intervertebral foramina. It is composed of branches from 
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the C1-3 ventral rami and consists of numerous interconnecting arcades. The deep 
cervical prevertebral plexus is located deep to the longus cervicis muscle and 
within the periosteum of the C2 vertebral body in its ventral gutter. It is formed from 
branches of the ventral rami of C3 and sometimes C4.14 This is also a likely 
explanation for the success of the anterolateral approach to lateral C1-2 joint PRF 
application in comparison with other approaches. PRF application at 45 V, 2 Hz, 
and 10 ms cycles for 10 minutes produces both early and late changes in the 
lateral C1-2 joint primary pain receptors and nerve endings. This extended electric 
field effects are also likely to have similar changes to the deep cervical prevertebral 
plexus and its branches, producing the observed increased duration of pain relief. 
Conclusion 
We conclude that PRF application of the lateral C1-2 facet joint is a feasible and 
safe technique in patients with cervicogenic headaches that are nonresponsive to 
other techniques such as radiofrequency denervation of lower cervical facet joints 
and cervical epidural injections. However, further prospective trials are required to 
validate this. In fact, we believe that this technique should be considered earlier in 
the course of the disease in view of its long-term efficacy as well as the possibility 
of improved efficacy if treated earlier. 
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Abstract 
Background: Whiplash patients regard cervicogenic headache (CEH) as the most 
burdensome symptom of their condition. Sufferers experience a significant degree 
of disability from headache, associated neck pain and disability, and sleep 
disturbance. Lateral C1/2 joint pulsed radiofrequency (PRF) treatment has been 
shown to produce significant relief from headache in patients with CEH. 
Objectives: The objective of this retrospective questionnaire study of 45 
consecutive whiplash patients with CEH who had undergone antero-lateral 
atlantoaxial joint pulsed radiofrequency treatment (AA PRF) was to evaluate the 
treatment’s long-term effects on pain-related disability and health-related quality of 
life. 
Patients and Methods: Four questionnaires were sent to all 45 patients who had 
undergone AA PRF: 1) The short form-36 (SF-36); 2) The neck disability index 
(NDI); 3) The medical outcome scale-sleep scale (MOS-SS); 4) The headache 
impact test-6 (HIT-6). All 45 patients received AA PRF under fluoroscopic 
guidance. PRF treatment was conducted at 45 V with a pulsed frequency of 4 Hz 
and a pulsed width of 10 ms for 4 minutes.  
Results: Patients who responded to the procedure reported lower pain scores at 2, 
6, and 12 months of follow-up compared to nonresponders. More important, 
patients reported marked improvements in headache impact (P < 0.01), neck-
disability scores (P < 0.01), awakening due to headache (P < 0.01), and sleep 
problems (9-item; P < 0.05) on the MOS-SS. Responders to the procedure also 
reported a significantly higher health-related quality of life in terms of bodily pain (P 
< 0.05) and health change (P < 0.01) on the SF-36. 
Conclusions: In light of the inherent limitations of our retrospective study, AA PRF 
treatment can only be tentatively viewed as a promising treatment modality for 
whiplash patients with CEH and is subject to validation in future studies. 
 
Background:  
The term cervicogenic headache (CEH) was first coined by Sjaastad et al. in 1983. 
In 1990 the CHISG criteria (cervicogenic headache international study group) for 
CEH was issued.1 Whiplash injuries were later implicated as likely triggers of CEH.1 
Whiplash-associated disorders (WAD) are very costly to society, and patients have 
rated headaches as the most burdensome WAD.2  
The prevalence of CEH had been estimated as high as 4.1% in the general 
population and as high as 17.5% among patients with severe headaches. For 
patients with headaches after whiplash, the prevalence is as high as 53%.3-5  
Most CEH sufferers experience a significant degree of disability from headache, 
associated neck pain, and sleep disturbance. It is often the disability emanating 
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from CEH attacks that compromises quality of life for these patients. Currently, no 
drugs are effective for CEH. A randomized controlled study showed that manual 
therapy alone was no more effective than exercise alone.6,7 Lateral C1/2 joint 
injections have identified the lateral C1/2 joint as a source of pain in patients with 
CEH.8-9 Narouze et al.10 found that 25% of their patients experienced 50% pain 
relief within 3 months. In a retrospective study with 86 patients, pulsed 
radiofrequency (PRF) application on the antero-lateral C1/2 joint (AA PRF) 
produced long-term pain relief up to 6 months, with more than 50% of patients 
experiencing pain relief of more than 50%.11  
Using cervical zygapophysial joint pain as a model for chronic neck pain, Wallis 
and colleagues showed that all patients who obtained complete pain relief 
exhibited resolution of their preoperative psychological distress, whereas those 
who were unrelieved continued to demonstrate signs of psychological distress.12 
 
Box 1. Clinical Criteria Used in Our Center for the Diagnosis of CE Attributable to Whiplash Injury 
Clinical Criteria for Cervicogenic Headache Attributable to Whiplash Injury 
1     Predominantly unilateral headache without side-shift 
2     Symptoms and signs of neck involvement: pain triggered by neck movement or external    
       pressure of the posterior neck or occipital region; ipsilateral neck, shoulder, and arm pain;  
       reduced range of motion. 
3     Pain episodes of varying duration or fluctuating continuous pain 
4     Moderate, non-excruciating pain, usually of a non-throbbing nature 
5     Whiplash injury sustained prior to onset of headache with no obvious neurological deficit (Grade  
       II Quebac Task Force classification) 
6     No direct head injury or any loss of consciousness 
 
Objectives 
This retrospective questionnaire study of 45 WAD patients with CEH who had 
undergone antero-lateral C1/2 joint PRF application (AA PRF) more than 1 year 
ago aimed to evaluate its AA PRF’s effects on pain-related disability and health-
related quality of life. 
Patients and Methods 
Institutional review board approval was obtained prior to administering the 
questionnaire to all patients. This retrospective questionnaire study included 45 
consecutive whiplash patients who had undergone lateral C1/2 joint PRF 
application for CEH in a single pain center in the Netherlands between January 
2007 and February 2009. The patients were recruited from a review of the pain 
center’s procedure records and verified with the individual patient’s medical 
records. All 45 patients who had fulfilled clinical criteria specified in Box, had 
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undergone cervical facet denervation (C3 to C5) prior to the antero-lateral C1/2 
PRF with minimal improvement. The lateral C1/2 joints in these 45 patients were 
found to be extremely tender, even after cervical facet denervation. All 45 patients 
were sent four questionnaires that included the Short Form-36 (SF-36)13, neck 
disability index (NDI)14, the medical outcome scale-sleep scale (MOS-SS)15, and 
the headache impact test-6 (HIT-6)16. All four questionnaires have been 
established for reliability and validity in the Dutch population.17-20 The patients were 
also sent a general personal data form that included a dichotomous question of 
whether they had experienced more than 50% pain relief after receiving the lateral 
C1/2 joint (AA PRF) injection. After all questionnaires were returned, post-AA PRF 
progress was evaluated by retrospectively retrieving pain scores (numerical rating 
scale of 0 to 10) of all 45 patients from individual case files. The NRS scores were 
retrieved at 2, 6, and 12 months. These data were all collected by an assistant not 
involved in the design of the study or in the analysis of the data.  
The technical details of the percutaneous procedure have been described 
elsewhere.11 A 22-G, 45-mm insulated radiofrequency needle with a 5-mm active 
tip was introduced percutaneously, under fluoroscopic control, so that it entered the 
lateral 1/3 of the of the antero-lateral C1/2 joint (Figure 1). Guided by fluoroscopy, it 
is important that the noninsulated needle tip does not contact either intra-articular 
osseous surface of the lateral C1/2 joint. This is to avoid causing the patient 
unnecessary pain during sensory stimulation. With the active tip within the intra-
articular space, sensory stimulation at 50 Hz up to 1.0 V and motor stimulation at 2 
Hz up to 1.0 V is almost always negative. PRF application at 45 V was then 
initiated with a pulse frequency of 4 Hz, pulse duration of 10 ms for 4 minutes. We 
do not routinely give contrast, local anesthetic, or steroids either before or after the 
PRF application.  
For the analysis of the MOS sleep scale, 90% completion of a section was 
considered sufficient for analysis. The HIT-6 and NDI scores were excluded if one 
item was missing. For the SF-36 subscale scores, missing values were substituted 
with group mean values in accordance with the instructions in the SF-36 manual. 
All statistics were performed using SPSS (version 16.0 for Windows). Descriptive 
statistics were generally reported as mean values ± 1 standard deviation (SD) and 
were analyzed for their degree of skewness or kurtosis. A student’s t-test 
(continuous variables) and Chi-square test (for dichotomous variables) were used 
to compare the differences in baseline characteristics and study measures 
between both groups. Pearson’s correlation coefficients were used to evaluate the 
correlation between questionnaire scores and their relevant domains. A 
significance level of P < 0.05 was used for all tests. 
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Results 
Thirty-six patients returned their questionnaires within 4 weeks. We attempted to 
contact the remaining 9 patients. Four patients returned their questionnaires after 2 
reminders (88.9%). We were unable to contact 1 patient. One patient agreed to the 
HIT-6 over the phone but not the rest of the questionnaires. Three patients 
agreed to the use of retrospective data but not to the questionnaires. Forty patients 
completed the SF-36 and NDI questionnaires, 39 patients completed the MOS-SS 
questionnaires, while 41 patients completed the HIT-6 questionnaires. Of the 44 
patients who consented to the study, 25 patients self-reported more than 50% pain 
relief at the time of the survey and were denoted as treatment responders 
(hereafter, responders). The remaining 19 patients reported less than 50% pain 
relief at the time of the survey and were denoted as treatment nonresponders 
(hereafter, nonresponders). The responders’ post-AA PRF improvement in pain 
scores was consistently lower than the scores of the nonresponders at 2, 6, and 12 
months (Table 1; P < 0.05). The baseline demographic characteristics of the 
responders and nonresponders did not differ significantly (Table 2). Additionally, 
the history of postprocedure employment, litigation, and government benefits did 
not differ either; the only demographic characteristic that did vary significantly was 
the age of the responders (t = -1.95, P < 0.058). 
The mean questionnaire scores (± SD) of both the responder and the 
nonresponder group are shown in Table 1. The HIT-6 and the NDI scores were 
significantly lower in the responder group than in the nonresponder group. The 
domains of awakening due to headache sleep problems Index I (6-items) and 
sleep problems Index II (9-items) in the MOS-SS were all significantly lower in the 
responder group than in the nonresponder group. Responders also had higher 
mean scores in all domains of the SF-36 (Table 1). However, this achieved 
statistical significance in only 2 subscales: bodily pain (t = -2.44, P < 0.05) and 
perception of health change (t = -3.60, P < 0.01), with role-physical being 
nonsignificant (t = -1.88, P = 0.68). 
The lower headache impact scores in the responder group correlated significantly 
with a decrease in neck disability (r = 0.64, P < 0.001) as well as with awakening 
due to headache (r = 0.55, P < 0.01) in the MOS-SS. The lower neck-disability 
score in the responder group also correlated significantly with a decrease in sleep 
problems and awakening due to headache (6-item: r = 0.36, P < 0.05; 9-item: r = 
0.44, P < 0.01) in the MOS-SS. The perceived improvement in health correlated 
well with a reduction in the impact of headaches on life (r = -0.54, P = 0.001), neck 
disability (r = -0.50, P = 0.001), and bodily pain (r = 0.67, P < 0.001). 
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Figure 1. Lateral View With a 5º Oblique Tilt for Initial Needle Entry (Left). Postero-Anterior View (Right) 
of Needle Entry into Lateral C1/2 Joint. Notice the Active Tip Does Not Contact the Intra-Articular 
Osseous Surface. 
 
Discussion 
From our retrospective findings, patients with sustained pain relief after AA PRF 
experienced improvements in headaches’ impact on life, reductions in neck 
disability, improvements with respect to sleep problems, and an improved overall 
perception of health within 12 months after treatment. The improvements in 
headaches’ impact on life were also highly correlated with improvements in neck 
disability and sleep. 
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Table 1. Questionnaire and Pain (NRS) Scores 
 Responder Group 
(n = 25) 
Non-Responder Group 
(n = 19) 
t score P value 
HIT-6 a, Mean ± SD 56.7 ± 11.7 68.6 ± 7.1 4.02 < 0.001 b 
NDI a, Mean ± SD 18.9 ± 8.4 27.1 ± 7.4 3.27 0.002 b 
MOS-SS a, Mean ± SD 
   Sleep disturbance 
   Snoring 
   Headache 
   Sleep adequacy 
   Somnolence 
   Sleep problems index I 
   Sleep problems index II 
 
44.8 ± 24.9 
42.9 ± 28.5 
44.5 ± 30.2 
43.2 ± 28.7 
35.8 ± 25.9 
41.2 ± 10.4 
42.5 ± 13.2 
 
55.3 ± 25.3 
29.4 ± 33.3 
72.9 ± 28.2 
32.4 ± 27.0 
46.7 ± 20.7 
48.2 ± 9.1 
51.1 ± 10.7 
 
1.30 
-1.32 
3.02
  
-1.21 
1.46 
2.25 
2.24 
 
0.203 
0.196 
0.005 b 
0.235 
0.152 
0.030 b 
0.031 b 
SF-36, Mean ± SD 
   Physical functioning 
   Role-physical 
   Bodily pain 
   General health 
 
63.9 ± 23.9 
37.0 ± 43.2 
55.8 ± 23.0 
53.3 ± 23.3 
 
57.4 ± 18.2 
16.2 ± 26.4 
41.1 ± 15.3 
49.7 ± 21.8 
 
-0.98 
-1.88 
-2.44 
-0.50 
 
0.331 
0.068 
0.020 b 
0.623 
Vitality, Mean ± SD   46.5 ± 21.8 42.4 ± 17.0 -0.68 0.500 
Social functioning, Mean ± 
SD  
61.4 ± 25.3 57.4 ± 16.0 -0.62 0.538 
Role-emotional, Mean ± SD    76.8 ± 38.2 58.3 ± 41.3 -1.42 0.166 
Mental health, Mean ± SD    70.3 ± 20.6 64.7 ± 18.6 -0.89 0.379 
Perceived health change, 
Mean ± SD  
65.2 ± 26.9 39.7 ± 17.8 -3.60 0.001 b 
NRS a scores, Mean ± SD 
   0 month 
   2 months 
   6 months 
   12 months 
 
8.68 ± 0.78 
1.64 ± 1.53 
1.68 ± 1.89 
1.45 ± 1.41 
 
8.32 ± 0.82 
6.00 ± 2.85 
6.53 ± 2.41 
7.74 ± 1.32 
 
1.46 
-5.98 
-7.08 
-14.71 
 
0.153 
< 0.001 b 
< 0.001 b 
< 0.001 b 
a Abbreviations: HIT-6; headache impact test-6; MOS-SS, medical outcome scale-sleep scale; NDI,   
  neck disability index; NRS, numerical rating scale 
b Denotes comparisons that are statistically significant at P < 0.05 
 
  
36 
Table 2. Baseline Characteristics of Treatment Responders and Nonresponders to Antero-Lateral C1/2  
              Joint PRFa 
 Non-responders 
(n = 19) 
Responders 
(n = 25) 
P value 
Age, y, Mean ± SD 41 ± 13 49 ± 11 0.05 
Gender, No. 
   Male 
   Female 
 
11  
 8 
 
16 
9 
0.68 
Height, cm, Mean ± SD  174 ± 9 171 ± 7 0.25 
Weight, kg, Mean ± SD  73.1 ± 14.5 70.0 ± 15.3 0.81 
Secondary education and above, No.  3  7  0.32 
Smoke, No.  7  4  0.12 
Alcohol, No.  7  10  0.79 
Years of pain, Mean ± SD  6.9 ± 9.4  7.1 ± 3.5 0.66 
Pre-procedure numeric rating scale (NRS)- 
score, Mean ± SD  
8.4 ± 0.8  8.6 ± 0.8 0.38 
Involved in litigation prior to procedure, No.  2  4  0.59 
Years post-procedure, Mean ± SD  2.0 ± 0.5  1.7 ± 0.7 0.39 
Currently employed, No.  9  10  0.59 
Returned to work, No.  10  11  0.82 
Benefits act from work loss or injury, No.  7  7  0.52 
a Abbreviation: PRF, pulsed radiofrequency 
 
The divergent pain scores between the responders and nonresponders at 2, 6, and 
12 months after AA PRF were reinforced by a self-reported improvement in general 
health by the responders. Despite consistently higher scores in all the health-
related, quality-of-life domains, we were limited by a relatively small sample size to 
detect significant improvements in those who responded to AA PRF. We are 
unable to conclude that the extended duration of pain relief observed in the 
responder group is entirely a result of antero-lateral C1/2 joint PRF due to inherent 
limitations in our retrospective study. However, our findings suggest that if whiplash 
patients with CEH do respond to intra-articular lateral C1/2 joint PRF, they may not 
only improve in terms of pain scores but also may exhibit positive changes to life 
burdens, neck-related disability, and perceived health over the long term.  
An extensive body of research is looking at the mechanisms through which PRF 
acts. At the time of this writing, most studies point towards an alteration in synaptic 
transmission in a neuromodulatory-type effect.21,22 The effects of PRF were initially 
postulated to be via a combination of excitatory C-fibre response suppression as 
well as inhibition of synaptic transmission with the decrease in excitatory 
postsynaptic potential.22-24 However, in intra-articular PRF, this is unlikely to be the 
case: the effects of intra-articular PRF are most likely a result of its anti-
inflammatory properties. This occurs as a result of the attenuation of 
proinflammatory cytokines such as interleukin (IL)-1b, tumor necrosis factor a 
(TNF-a), and IL-6 by the generated electric fields.25,26 In fact, IL-1b, which is 
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present in high amounts in OA cartilage, is considered to be one of the main 
catabolic factors involved in the cartilage matrix degradation.27,28 In addition, an up-
regulation of adenosine A2a receptor density has been observed in human 
neutrophils treated with pulsed electric fields.29 Activation of adenosine A2a 
receptors seems to be associated with inhibition of the catabolic cytokines TNF-a, 
IL-6, and IL-8.30,31 It seems intuitive to presume a similar mechanism of action of 
the A2a receptor on chondrocyte membranes, with a similar consequential effect of 
cytokine inhibition.27,31 
One of the hypotheses generated from this retrospective study is thus the 
chrondro-protective mode of action of intra-articular PRF, which may explain the 
anecdotal observation of pain relief 2 to 4 weeks after PRF in a number of patients. 
A number of in-vitro studies have shown that chondrocyte proliferation and matrix 
synthesis are significantly enhanced by pulsed electrical fields.28,32-34 Fini et al.27 
suggest that the delivery of pulsed electromagnetic fields combines an anabolic 
effect on chondrocytes, a catabolic cytokine blockage, a stimulatory effect on 
anabolic cytokine production, and a counteraction of the inflammatory process in 
osteoarthritis. Cosman et al.35 assert that magnetic fields generated in PRF are 
negligible and any therapeutic effects are due to the electric fields. More research 
will therefore be required to verify in-vitro effects, if this hypothesized chondro-
protective mechanism is indeed true.  
The main limitation of our study is the lack of a control group. The retrospective 
nature of the study and the relatively small sample size also prevent strong 
conclusions regarding the efficacy of antero-lateral C1/2 PRF for whiplash patients 
with CEH. 
As we attempt to prospectively evaluate our results in a formal trial, more studies 
will be also needed to evaluate other treatment modalities in this multifaceted 
clinical diagnosis. It seems prudent to adopt an algorithmic approach in the 
management of such patients, and at the time of this writing, antero-lateral C1/2 
joint PRF should be at most be regarded as a potentially viable treatment modality 
subject to validation in future studies.  
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Abstract 
Background: Pulsed radiofrequency (PRF) treatment is defined as the delivery of 
short pulses of radiofrequency via a needle tip, which does not result in an actual 
thermal lesions. There are mixed views regarding the use of PRF for trigeminal 
neuralgia (TN). In our opinion, one of the main reasons for the contrasting views is 
the insufficient PRF dose employed in previous studies. In a recent study on the 
effects of PRF on resiniferatoxin induced neuropathic pain in an animal model, the 
anti-allodynic effects of PRF were significantly greater when the PRF exposure 
duration was increased from 2 to 6 minutes. 
Objectives: The primary objective of this retrospective study is to report the results 
for 36 consecutive patients who underwent PRF treatment for TN, for 6 minutes at 
45 V at a pulsed frequency of 4 Hz and a pulse width of 10 ms. 
Patients and Methods: For the study, we obtained procedural records of 36 
consecutive patients. Their current state of pain was evaluated over a telephonic 
survey and the post-procedural data at 2, 6, and 12 months were retrieved 
thereafter from the patient records. The main outcome measure was excellent pain 
relief (more than 80%), which was assessed at 2, 6, and 12 months. 
Results: The percentages of patients who showed excellent pain relief (> 80% 
pain relief) at 2, 6, and 12 months were 73.5% (25/34), 61.8% (21/34), and 55.9% 
(19/34), respectively. The percentages of patients showing satisfactory pain relief 
(50–80% pain relief) at 2, 6, and 12 months were 14.7% (5/34), 17.6% (6/34), and 
17.6% (6/34), respectively, and those of patients showing less than satisfactory 
pain relief (< 50% pain relief) at 2, 6, and 12 months were 11.8% (4/34), 20.6% 
(7/34), and 23.5% (8/34), respectively. No complications were reported, and none 
of the patients required hospitalization.  
Conclusions: PRF of the trigeminal ganglion should be further evaluated as an 
alternative treatment method for TN. 
Background 
The International Headache Society classifies trigeminal neuralgia (TN) into 
classical and symptomatic TN, with the latter being clinically indistinguishable from 
the former. The only identifiable difference between the 2 conditions is that in 
symptomatic TN, a causative lesion (other than vascular compression) can be 
detected, and has been demonstrated in imaging or posterior fossa exploration 
(International Classification of Headache Disorders-II).1 In clinical practice, 2 
phenotypic forms of TN are usually recognized, typical and atypical TN.2-4 The 
hallmark of typical TN is paroxysmal pain, which is lancinating in nature and occurs 
unilaterally in a trigeminal distribution.5 Paroxysmal pain is present in atypical TN 
as well, but patients often report it along with diffuse and chronic pain, which 
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persist beyond the duration of a typical paroxysm, in the same trigeminal 
distribution areas. The paroxysmal pain distinguishes atypical TN from persistent 
idiopathic facial pain, which was previously known as atypical facial pain.1 
Carbamazepine is the drug of choice in the initial treatment of idiopathic TN. 
However, some patients develop adverse effects while some others do not show 
sustained pain relief.5 For cases in which conservative treatment is not successful, 
invasive treatment can be considered. The available options include surgical 
microvascular decompression (MVD)6,7, surgical sectioning of a portion of the 
sensory component of the trigeminal nerve, stereotactic radiation therapy or 
gamma knife treatment8, percutaneous balloon microcompression9, percutaneous 
glycerol rhizolysis10, and percutaneous radiofrequency (RF) thermocoagulation of 
the Gasserian ganglion11. In addition to the operative risks inherent in surgical 
techniques, all neurodestructive methods present risks of sensory loss, 
dysesthesia, anesthesia dolorosa, corneal anesthesia, and facial muscle 
weakness.12,13 
Pulsed radiofrequency (PRF) treatment is defined as the delivery of short pulses of 
RF via a needle tip, thereby avoiding thermal lesions. This technique had been 
performed for various other conditions and has been shown to be effective and 
safe. There are contrasting opinions regarding the use of PRF treatment for 
TN14,15, but in our opinion, one of the main reasons for this discrepancy is the 
insufficient PRF dose used in most studies. 
Objectives 
In a recent study on the effects of PRF on resiniferatoxininduced neuropathic pain 
in an animal model, the anti-allodynic effects of PRF were significantly greater 
when the PRF exposure duration was increased from 2 to 6 minutes.16 We present 
a retrospective study of 36 patients with TN who underwent PRF treatment of the 
trigeminal ganglion for 6 minutes at 45 V, pulse frequency of 4 Hz, and pulse width 
of 10 ms. 
Patients and Methods 
3.1. Subjects 
Institutional research review board approval was obtained prior to the retrospective 
collection of patient data. All patients presenting at our hospital with refractory 
facial neuralgia undergo a multidisciplinary assessment, including complete 
neurological evaluation and magnetic resonance imaging (MRI). This retrospective 
study included all 36 patients who underwent lateral trigeminal ganglion PRF 
treatment for typical and atypical TN at a single pain centre from January 2007 to 
April 2009. All the therapeutic procedures were performed by 2 pain physicians at 
44 
our pain centre. A referring neurologist excluded secondary causes of the pain 
after studying MRI reports. All 36 patients presented with lancinating, burning, or 
aching unilateral severe facial pain, in one or more of the trigeminal nerve 
distributions; a small proportion of patients also experienced chronic background 
pain. Typical trigger points on the face in one or more of the trigeminal nerve 
distributions were observed in both patients with typical and atypical TN. Distinct 
triggering stimuli or activities such as touch, cold wind on the face, chewing, 
talking, and yawning were also commonly reported. Many of the painful episodes 
or paroxysms lasted from minutes to hours, but the episodes rarely lasted for 
days. Some patients reported that initial treatment with drugs such as 
carbamazepine, phenytoin, or gabapentin was effective, but their pain relief was 
rarely sustained. 
3.2. Procedure 
The percutaneous technique was performed as first described by Sweet et al.11 in 
1974. In this procedure, the patient lies comfortably in a supine position with the 
head slightly extended. Electrocardiogram and pulse oximetry and blood pressure 
readings are obtained for continuous hemodynamic monitoring. The C-arm is 
introduced in a postero-anterior fashion and rotated caudo-cranially to produce a 
submental view. The foramen ovale can be often already visualized with this view. 
A 5–10-degree tilt to the ipsilateral affected side may be required to improve 
visualization of the foramen ovale, as shown in Figure 1. The needle entry point is 
2–3 cm from the corner of the mouth. An approach that worked well for us was to 
“bring the foramen ovale to the entry point” by manipulating the C-arm in a caudo-
cranial orientation, which produced an excellent “tunnel view.” 
The skin over the needle entry point is anesthetized with 1% lidocaine. Using an 
aseptic technique, the needle is directed towards the ipsilateral pupil. We follow the 
practice of keeping 1 finger in the mouth of the patient to reduce the chance of 
needle entry into the oral cavity. If the oral cavity is breached, the needle is 
replaced to reduce the rate of infectious complications. Up to 0.75 mg/kg of 
propofol is used to sedate the patient during the initial needle penetration into the 
foramen ovale. Once the needle enters the foramen ovale into Meckel’s cavity, the 
C-arm is then rotated laterally to ascertain the depth of penetration. The final 
position of the needle tip is just past the angle formed by the petrosal ridge of the 
temporal bone and the clivus. The propofol sedation is discontinued, the patient is 
allowed to awaken, and sensory stimulation is carried out at 50 Hz. The definitive 
position of the electrode was verified by inducing paresthesia with sensory 
stimulation between 0.1–0.3 V in the affected painful area. PRF is then applied for 
6 minutes at 45 V, with a pulse width of 10 ms and a pulse frequency of 4 Hz. The 
cut-off needle tip temperature was set at 42 °C. 
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3.3. Patient Data Collection 
In March 2010, an assistant attempted to contact all the 36 patients who had 
undergone lateral trigeminal ganglion PRF application for typical and atypical TN, 
in a single pain centre from January 2007 to April 2009, to enquire about their 
current status. After the telecommunication process was completed, retrospective 
patient data were retrieved from individual patient records. The perceived effect for 
each patient was recorded in the form of a Likert scale as a part of our routine clinic 
follow-up intervals at 2 months, 6 months, and 12 months. Perceived effect was 
recorded as a) less than 50% relief; b) 50–80% pain relief; c) more than or equal to 
80% pain relief. The data entry was performed by another assistant who was not 
involved in the design of the study or in the analysis of the data. Descriptive 
statistics were generally reported as mean ± SD. Frequency counts were used to 
summarize categorical data. All statistical analyses were performed using the 
SPSS software package for Windows (version 16.0). 
Results 
The pain centre procedural records showed that 36 patients had undergone PRF 
treatment on the trigeminal ganglion from January 2007 to January 2009. A mean 
duration of 2.3 ± 0.8 years have elapsed since the last PRF procedure in this group 
of patients, of which 67.6% still reported satisfactory pain relief. Of these 36 
patients, 1 died and 1 underwent a neurosurgical procedure soon after the PRF 
and was unwilling to participate in the evaluation. The remaining 34 patients 
consented to the use of their retrospective data for analysis. The baseline 
characteristics of the 34 patients are shown in Table 1. The distribution of the 
affected trigeminal branches is shown in Figure 2.  
 
Table 1. Baseline Characteristics of Patients Who Underwent Trigeminal Ganglion PRFa 
Baseline Characteristics  Patients, (n = 34) 
Gender, No. (%) 
   Males  
   Females 
 
11 (32.4) 
23 (67.6) 
Age, y, Mean ± SD 73 ± 14 
Duration of pain, y, Mean ± SD 7.2 ± 6.2 
VAS a before TG a PRF a, Mean ± SD  8.7 ± 0.7 
a Abbreviations: PRF, pulsed radiofrequency; TG, trigeminal ganglion; 
VAS, visual analogue scale 
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Figure 1 (Left). Submental View (With a 5 °Oblique Tilt) of the Foramen Ovale and Lateral View to 
Confirm the Depth of Needle Insertion 
Figure 2 (Right). Distribution of Affected Trigeminal Branches  
 
From the retrospective review of the documented clinical results of all 34 patients, 
the percentages of patients who showed excellent pain relief (≥ 80% pain relief) at 
2, 6, and 12 months were 73.5% (25/34), 61.8% (21/34), and 55.9% (19/34), 
respectively. The percentages of patients with satisfactory pain relief (50–80% pain 
relief) at 2, 6, and 12 months were 14.7% (5/34), 17.6% (6/34), and 17.6% (6/34), 
respectively, and those of patients showing less than satisfactory pain relief (< 50% 
pain relief) at 2, 6, and 12 months were 11.8% (4/34), 20.6% (7/34), and 23.5% 
(8/34), respectively. No complications were reported, and none of the patients 
required hospitalization.  
Discussion 
To our knowledge, this is the largest series of TN patients treated with PRF. 
Among these patients, 67.6% continued to report satisfactory pain relief after 2.3 ± 
0.8 years of PRF treatment. This data correlated well with our records of excellent 
and satisfactory rates of pain relief at 6 and 12 months. This may mean that good 
pain relief at 6–12 months after trigeminal ganglion PRF treatment may predict for 
long-term efficacy using PRF treatment. The affected trigeminal branch 
distributions in all 34 patients in our series were similar to those reported in the 
literature.5,17 
In a prospective case series, reported by Van Zundert et al.14, 5 high-risk patients 
received administered PRF treatment for the trigeminal ganglion. The first 4 
patients experienced excellent pain relief over an average of 17.5 months, even 
though 1 of them required a repeat procedure. In patient 5, despite a reduction in 
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pain intensity and frequency, the patient received conventional RF rhizotomy of the 
trigeminal ganglion at another centre 5 months later, with only minimal relief. This 
patient was eventually referred for microvascular decompression after 26 months. 
Our findings for this small but well-conducted case series reinforce the potential 
efficacy of PRF treatment in TN. 
In the largest review till date, Kanpolat et al.13 reported the results for 1,600 
patients who had undergone percutaneous RF trigeminal rhizotomy over a period 
of 25 years. The complications reported in this large study were decreased corneal 
reflex (5.7%), weakness and paralysis of the masseter muscle (4.1%), dysesthesia 
(1%), anesthesia dolorosa (0.8%), keratitis (0.6%), and temporary paralysis of the 
third and fourth cranial nerves (0.8%). Complications like anesthesia dolorosa, 
though considered rare by some, are regarded to be worse than the initial pain of 
TN. It was perhaps for this reason that PRF was explored as a less risky 
alternative. However, Erdine et al.15 demonstrated in a double-blinded trial that 
PRF was remarkably less efficacious that conventional RF. Their results 
demonstrate significant pain reductions in all patients treated with conventional RF, 
while only 2 of the 20 patients in the PRF group experienced this level of pain 
relief. We wish to highlight some pertinent observations that may explain the lower 
efficacy in the PRF group in comparison with the efficacy in the conventional RF 
group in that study. 
The authors in that trial used the well-accepted meticulous process of conventional 
RF of the trigeminal ganglion. RF thermocoagulation at 70 °C for 60 s was carried 
out, and the sensitivity of the affected area of the face and cornea were tested 
thereafter. If more than 1 branch of the TN was affected, second or more 
procedures were performed by repositioning the needle tip and waiting for 
paresthesia after each procedure. Such a meticulous process, however, was not 
described for PRF. It appears that they performed a PRF treatment procedure, 
wherein 2 bursts of 20 ms were applied for 120 s at an output of 45 V.15 
Notwithstanding the different end-points of both treatments, we feel that an unfair 
comparison had been made with regard to 2 aspects: 
1) Similar to RF, if more than 1 branch of the trigeminal nerve is affected, PRF 
application to other affected trigeminal distributions is equally important.  
2) In our experience, PRF treatment with a pulsed width of 20 ms and frequency of 
2Hz for 2 minutes is insufficient for TN. 
In the case series by Van Zundert et al.14, 1 patient who required a second 
procedure had more than 1 trigeminal branch. Even in our retrospective study, 5 
out of 34 patients (14.7%) required more than one session of PRF treatment. The 
reason for this could be due to the neuromodulatory mode of action of PRF, which 
does not produce immediate paresthesia as in RF thermocoagulation. With regards 
to the second point, we applied PRF at 45 V, with a pulsed width of 10 ms, and a 
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pulsed frequency of 4 Hz for 6 minutes. This higher PRF dose has recently been 
validated in an animal neuropathic pain-model study whereby PRF was applied to 
the sciatic nerve 1 week after induced injury for 2, 4, and 6 minutes.16 The group 
where PRF was applied for 6 minutes showed increased withdrawal latency-
increased anti-allodynic effects, than the groups with 2 or 4 minutes of PRF 
application. 
A systematic review of ablative neurosurgical techniques for the treatment of TN 
evaluated 166 studies reporting RF thermocoagulation, glycerol rhizolysis, balloon 
compression of the trigeminal ganglion, and stereotactic radiosurgery and 
concluded that RF thermocoagulation offers the highest rates of complete pain 
relief.2 In our opinion, RF trigeminal rhizotomy is still an invaluable technique that 
has provided pain relief for many patients with TN. In our opinion, PRF needs to be 
performed to a similar degree to be compared in the same light. It may be prudent 
to even consider performing PRF prior to RF for a sole purpose of avoiding 
disturbing sensory paresthesia and masseter paralysis. 
The limitations of this study are inherent to retrospective studies of such nature, in 
which data have been collected in a clinical context and cannot, for example, allow 
quantification of the changes in pain medications over 1 year of follow-up. PRF 
treatment of the trigeminal ganglion may be a possible alternative to minimally 
invasive treatment in the management of TN. The possibilities of reduced heat-
related complications and comparable efficacies to conventional modalities need to 
be evaluated in greater detail in further studies. 
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Abstract 
Background: Percutaneous cervical nucleoplasty (PCN) is a safe and effective 
treatment in symptomatic patients with contained cervical herniated disks. It 
provides simple and efficient disk decompression, using a controlled and highly 
localized ablation, but evidence regarding long-term efficacy is limited. We 
conducted a retrospective study to investigate the long-term efficacy and safety of 
PCN, and the influence of ideal selection settings. 
Methods: A total of 27 patients treated with PCN fulfilling ideal selection criteria 
(Group A) were studied and compared to 42 patients not meeting these criteria 
(Group B). Outcomes were assessed using the Visual Analogue Scale (VAS) and a 
four-level Likert item for perceived pain and satisfaction, the Neck Disability Index 
(NDI), and the Short Form 36 (SF-36). Additional relevant outcomes were retrieved 
from medical records.  
Results: The postoperative mean VAS pain for Group A was 29.9 (SD ± 32.6) at a 
meanfollow-up of 24 months (range: 2–45). Only 10% of these patients reported 
mild transient adverse events. There was a trend, but no difference between both 
groups in pain scores; however, treatment satisfaction was higher for Group A 
(74.1 ± 27.2–55.5 ± 31.4, P = 0.02). Group A also reported better physical 
functioning based on the Physical Component Summary (43.6 ± 10.6–37.3 ± 12.0, 
P = 0.03) and showed a larger proportion of patients no longer using any 
medication postoperatively (63–26%, P = 0.01).  
Conclusion: These results show long-term effectiveness and safety of PCN in 
patients with a one-level contained cervical herniated disk, and the reliance of 
selecting patients meeting ideal criteria for successful PCN.  
Introduction 
Pain stemming from intervertebral disk pathology is difficult to manage and is costly 
to healthcare organizations around the world.1,2 Pain from intervertebral disks may 
be caused by mechanical compression from extruded disk material, accompanying 
inflammatory response, and released chemical mediators.3 
The move toward minimally invasive spine surgery is partially driven by various 
factors including the desire to reduce surgery-related trauma, patients’ awareness 
of alternatives to open surgical procedures, and the development of new 
technologies.1,2,4–6 Disk decompression relieves symptoms in patients with 
contained herniated disks at both the cervical and lumbar spine.7 Chemical, 
mechanical, and thermal methods have been utilized, and percutaneous cervical 
nucleoplasty is one such method.7 Its basic principle is that a small reduction in 
volume in a hydraulic space, like an intact disk, results in a disproportionately large 
fall in pressure. Ablation of approximately 1 mL of disk tissue volume corresponds 
to a diskal pressure reduction of about 10–20%,4–6 resulting in a reduction in pain.6 
It is a minimally invasive procedure aimed at relieving pressure on sensory 
structures while minimizing trauma to normal tissues and enhancing patient 
recovery.1,5,6 
Studies have demonstrated percutaneous cervical nucleoplasty (PCN) to be both 
safe and effective.1,3–7 
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Strict patient selection is believed to be of significant importance for successful 
treatment.3,6 PCN uses Coblation Technology6 whereby a portion of the nucleus 
tissue is ablated using a 1-mm-diameter bipolar instrument that creates 
radiofrequency energy.6 This results in ablation of a portion of nucleus tissue with a 
lowtemperature (typically 40–70°C) plasma field of ionized particles.2,6 These 
particles have sufficient energy to break down organic molecular bonds within the 
tissue, dissolving the soft tissue material of the disk nucleus.2,6 The procedure 
provides a simple and efficient disk decompression method, using a controlled and 
highly localized ablation, with minimal damage to surrounding healthy tissue.2,4,6,7 
There is little information on the long-term outcomes after PCN.2,7 The primary 
objective of this retrospective study was to evaluate the long-term efficacy of PCN 
based on degree of pain relief, patient satisfaction, functional improvement, usage 
of pain medications, and incidence of adverse events, in symptomatic patients with 
one-level contained cervical herniated disk complaining of radicular pain. The 
secondary objective of this study was to evaluate the influence of nonideal patient 
factors in postprocedure outcomes when compared to ideal selection settings. 
Patients and methods 
Due to the retrospective study design, this study was exempted from review by an 
institutional review board under Dutch national law.  
Patient Population  
One hundred twenty-one consecutive PCN procedural records from 2 general 
district hospitals in the Netherlands, performed between May 2007 and July 2011 
on 115 patients, were reviewed, and the workflow is shown in Figure 1. Thirty-eight 
patients with a singlelevel contained cervical herniated disk diagnosed on 
preoperative Magnetic Resonance Imaging (MRI) and confirmed by a diagnostic 
selective nerve root block were identified. These patients failed conservative 
therapy and complained mainly of radicular pain with or without neck pain (Group 
A). We considered these as the most important selection criteria for successful 
PCN. Sixty-five patients who were treated with PCN, but did not fulfill all these 
criteria, were identified (Group B). These patients, either or not with previous neck 
surgery, formed a mixed group of indications based on preoperative MRI findings 
of either multi- level cervical discopathy, disk prolapse with an extruded or 
sequestrated disk fragment, bulging disk only with no clear evidence of herniation, 
spinal canal stenosis, uncovertebral arthrosis, hypertrophy of the posterior 
longitudinal ligament, or cervical osteophytes. All patients were sent questionnaires 
to assess perceived pain and satisfaction using a Visual Analogue Scale (VAS)-
100 mm and a four-level Likert item. Functional outcomes and quality of life scores 
were measured using the Neck Disability Index (NDI)8 and the Short Form 36 (SF-
36).9 The incidence of complications and side effects, recurrence of symptoms, and 
pre- and postoperative pain medication use were retrieved from medical records. 
Reminders by mail (twice) and by phone (once) were used to increase the 
response rate. 
 
 
 
54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of the group allocation of the study population. 
 
Percutaneous Cervical Nucleoplasty Procedure 
The protocol of the percutaneous cervical nucleoplasty procedure had been 
described previously.3 Four pain physicians from the 2 different centers performed 
the procedures. Intravenous prophylactic antibiotics of cefazolin 1 g or augmentin 
2.2 g were administered before the start of the procedure. Under aseptic 
conditions, a 19-gauge Trocar 3-inch spine needle (Arthro-Care Co., Sunnyvale, 
CA, USA) was inserted into the annulus fibrosis of the herniated disk from a 20–
30° oblique approach (Figure 2). The lateral view was then used to confirm its final 
depth. The Perc DC SpineWand (ArthroCare Co.) was then used to create 2 small 
360° lesions at different depths after coagulation check. Patients were discharged 
on the same day at one center, after one night stay at the other center, and a 
follow-up visits were scheduled 2 months after the procedure. Soft cervical bracing 
was applied for 3 days.  
 
12 patients without 
pre-operative MRI 
findings 
103 patients 
121 consecutive cases 
(May 2007- July 2011) 
115 patients 
Group B (n = 65) 
27 respondents (71%) 
Group A (n = 38) 
42 respondents (65%) 
6 patients underwent 
>1 cervical nucleo- 
plasty procedure 
Ideal selection 
criteria 
Questionnaires were sent twice and one 
reminder call was made 
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Statistical Analyses 
Neck Disability Index scores were excluded if one item was missing. For the SF-36, 
missing values were substituted by mean group values. Data are presented as 
mean ± standard deviation (SD). For the comparison of baseline characteristics 
and study measures between group A and B, an independent samples t-test, a 
chisquare test, or a Fisher exact probability test was used, depending on variable 
type. For normal distributed data, Spearman’s rank correlation coefficients were 
calculated to investigate correlations between the means of both the VAS pain and 
VAS satisfaction, and categories of reported pain change for both groups. These 
analyses were also performed for the categories of patient reported satisfaction in 
both groups. A Pearson’s correlation coefficient was calculated to evaluate the 
correlation between the NDI and Physical Component Summary (PCS). The level 
of statistical significance was set at P < 0.05 for all tests. Statistical analyses were 
performed using SPSS version 19.0 (SPSS Statistics, IBM corporation, Somers, 
NY, USA). 
 
 
Figure 2. C-arm fluoroscopic images in oblique, anteroposterior and lateral planes of the needle onto 
the intervertebral disc level C4-C5. Images belong to Frank Blommers, Diagnostic radiographer, Albert 
Schweitzer Hospital, Sliedrecht, the Netherlands and are used after reprint request. 
Results 
Group A 
The questionnaire response rate for Group A was 71% (16 men and 11 women 
patients). Mean age was 53 years (SD ± 8.0) (Table 1). Mean follow-up was 24 
months (range: 2–45). Group A reported a mean VAS pain score of 29.9 (SD ± 
32.6) with complete or partial pain relief in 78% of the patients (Table 2). The mean 
satisfaction score was 74.1 (SD ± 27.2) with 63% being satisfied or very satisfied. 
The VAS for pain correlated significantly with both categories of patient reported 
pain change (rs = -0.904, P < 0.001) and satisfaction (rs = -0.891, P < 0.001) 
56 
(Figure 3), and the VAS for satisfaction, respectively rs = +0.862, P < 0.001 and rs = 
+0.932, P < 0.001 (Figure 4). The NDI (n = 20) resulted in a mean neck disability 
percentage of 16.9 (SD ± 16.2). The SF-36 (n = 27) showed a mean PCS of 43.6 
(SD ± 10.6) and Mental Component Summary (MCS) of 49.4 (SD ± 10.0). 
Complete details on pain medication use before and after treatment were available 
from 19 patients. All 19 used pain medication preoperatively. Postoperatively, 
almost 2/3 of all patients no longer used pain medication (63%), while usage was 
diminished in 16%, equal in 16%, and increased in 5%. Details on complications 
were retrieved from 20 patients. Two patients reported transient possible 
complications. One reported disturbed vision and a mild headache, which both 
resolved within a few days. One patient had mild tingling in the right arm and leg, 
which resolved later. The majority (90%) reported no complications. Four patients 
needed further treatment for persistent pain. One underwent cervical discectomy, 
another was treated with pulsed radiofrequency (PRF) first and discectomy later, 
the third received an epidural steroid injection, and the fourth patient received a 
nerve root block. Of these patients, the first 2 reported still no improvement, while 
the latter 2 improved. 
Group A vs. B 
Within Group B, 42 patients (65%) returned their questionnaires. This group 
consisted of 22 men and 20 women with a mean age of 50 (SD ± 7.1) years (Table 
1). At a mean follow-up of 24 months (range: 3–45), the mean VAS pain score for 
Group B was 42.4 (SD ± 31.2) with complete or partial pain relief in 60% of the 
patients (Table 2). Both scores did not differ significantly from Group A. The mean 
VAS satisfaction was 55.5 (SD ± 31.4) with 53% being satisfied or very satisfied, 
resulting in a significant higher VAS satisfaction score in Group A (t = +2.45, P = 
0.02). Although Group A showed a larger patient proportion being satisfied or very 
satisfied, this difference was not significant. Within Group B, as well the VAS pain 
correlated significantly with both categories of patients reporting pain change (rs = -
0.889, P < 0.001) and satisfaction (rs = -0.870, P < 0.001) (Figure 5), as the VAS 
satisfaction, respectively, rs = +0.872, P < 0.001 for both categories (Figure 6). The 
NDI (n = 36) resulted in a mean neck disability percentage of 27.5 (SD ± 22.5). The 
SF-36 (n = 42) showed a mean PCS of 37.3 (SD ± 12.0) and MCS of 49.2 (SD ± 
10.7). Although a negative correlation was found between the NDI and PCS in both 
groups and overall (r = -0.71, P < 0.0001), only the PCS was significant higher in 
group A (t = +2.20, P = 0.03). Complete details on pain medication use in Group B 
were known from 30 patients. Three patients did not use any pain medication pre- 
and postoperatively, while 27 patients (90%) used pain medication preoperatively. 
Over 1/4 of these 27 patients did not use any pain medication postoperatively 
(26%), while usage diminished in 30% was equal in 33% and increased in 11%. 
The percentages of decrease in pain medication use did not differ between group 
A (79%) and B (56%). 
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Table 1. Baseline Characteristics 
Characteristics Group A (n = 27) Group B (n = 42) P value 
Gender  
   Male  
   Female  
 
16 
11 
 
22 
20 
 
0.58 
Mean age (years) 53 (SD ± 8.0) 50 (SD ± 7.1) 0.13 
Number of herniated discs per level 
   C3/4  
   C4/5   
   C5/6 
   C6/7 
 
1 
1 
9 
16 
 
1 
8 
25 
16 
 
Number of patients with uni-/multilevel herniation 
   Unilevel 
   Multilevel 
 
27 
0 
 
34 
8 
 
Mean duration of pain (months) 16 (SD ± 21) 37 (SD ± 35) 0.01 
Mean follow-up duration (months) 24 (Range: 2–45) 24 (Range: 3–45) 0.91 
Cases per follow-up term 
   0–12 months (short/mid) 
   > 12 months (long)  
 
  5 
22 
 
8 
34 
 
1.00 
 
SD, standard deviation. 
The Bold represents significant P-values. 
 
Table 2. Patient Reported Outcomes 
Patient 
Reported 
Outcomes 
 Group A Group B P value 
Reported pain  Complete pain relief 
Partial pain relief 
No improvement 
Worse pain 
Not reported 
11 (41%) 
10 (37%) 
4 (15%) 
2 (7%) 
N/a 
9 (22%)  
16 (38%) 
10 (24%) 
  6 (14%) 
  1 (2%) 
0.12 
Mean VAS pain (± 
SD) 
 29.9 (± 32.6) 42.4 (± 31.2) 0.16 
Reported 
satisfaction 
 
Very satisfied  
Satisfied  
Somewhat  satisfied 
Dissatisfied  
Not reported  
10 (37%)  
  7 (26%)  
  6 (22%) 
3 (11%)  
  1 (4%) 
10 (24%)  
12 (29%) 
14 (33%) 
  6 (14%)  
N/a 
0.39 
Mean VAS 
satisfaction (± SD) 
 74.1 (± 27.2) 55.5 (± 31.4) 0.02 
Mean NDI (± SD)  16.9 (± 16.2) 27.5 (± 22.5) 0.08 
SF-36  
 
Mean PCS (± SD) 
Mean MCS (± SD) 
43.6 (± 10.6) 
49.4 (± 10.0) 
37.3 (± 12.0)  
49.2 (± 10.7) 
0.03 
0.94 
Medicatio before 
 
Yes  
No  
19 (100%)  
  0 (0%) 
27 (90%) 
  3 (10%) 
0.27 
Medication after No medication  
Less medication  
Stable medication 
Increased medication 
12 (63%) 
  3 (16%)  
  3 (16%) 
1 (5%) 
7 (26%)  
  8 (30%)  
  9 (33%) 
  3 (11%) 
0.01* 
0.10† 
 
Complications  Yes  
No  
2 (10%)  
18 (90%) 
1 (4%)  
27 (96%) 
0.56 
Further treatment 
needed 
Yes  
No  
4 (15%)  
23 (85%) 
2 (5%)  
40 (95%) 
0.20 
 
Abbreviations table 2: VAS, visual analogue scale; SD, standard deviation; NDI, neck disability index; 
SF-36, short form-36; PCS, physical component summary; MCS, mental component summary. 
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*No medication group A vs. B. 
†No + Less medication group A vs. B. 
The Bold represents significant P-values. 
 
 
 
Figure 3. Categories of patient reported pain change and satisfaction representing the mean VAS score 
pain including added trend lines for group A. 
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Figure 4. Categories of patient reported pain change and satisfaction representing the mean VAS score 
satisfaction including added trend lines for group A. 
 
 
 
Figure 5. Categories of patient reported pain change and satisfaction representing the mean VAS score 
pain including added trend lines for group B. 
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Figure 6. Categories of patient reported pain change and satisfaction representing the mean VAS score 
satisfaction including added trend lines for group B. 
 
Of these proportions, 63% of Group A compared to 26% of Group B no longer used 
medication, resulting in a significant difference (φ = -0.37, P = 0.01). Details on 
complications were retrieved from 28 patients. One patient reported neck stiffness 
and restricted motion after treatment, but this resolved after a short period. The 
majority (96%) reported no complications. Percentages of reported complications 
differed somewhat between Groups A and B, but not significantly. Within Group B, 
2 patients needed further treatment because of persistent pain. One received a 
cervical epidural steroid injection first and had a neuromodulator implanted later. 
One got a neuromodulator implanted. The first patient improved, while the latter 
reported still no improvement currently. There was no difference between Groups A 
and B in the proportion of patients requiring further treatment.  
Discussion 
From our results, it is clear that complete or partial longterm pain relief can be 
safely achieved using PCN in patients with a one-level contained cervical herniated 
disk. In the majority of these patients, PCN leads to long-term reduction in pain, 
good clinical outcomes, reduced pain medication use, and high patient satisfaction. 
Our results also indicate that ideal selection criteria lead to better pain relief, higher 
satisfaction rates, a larger reduction in the use of pain medication, and better 
clinical outcomes. 
Our long-term high rates of pain improvement and patient satisfaction in Group A 
are similar to short-term results of other studies. Both Li et al.4 and Sim et al.3 
showed a high rate of excellent and good patient satisfaction after PCN, 
respectively, 83.7% and 77.3%. Bonaldi et al.10 reported successful PCN in 85% of 
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their treated patients. These studies reported mean postprocedure VAS pain 
scores ranging from 2.4 to 3.7 on a 10-cm scale, but only for short and mid-term 
follow-up.3,4 A recent systematic review on effectiveness of nucleoplasty 
represented mean pooled VAS pain scores for short and mid-term follow-up of ± 
4.0.6  These figures agree with our result (converted to a 10-cm scale) of the mean 
VAS pain score for group A of 2.99. Within this group, pain medication use was 
diminished in 79% of the cases, and almost two-thirds of all patients did not use 
any pain medication at all after treatment (63%). The low complication rate found in 
our study is comparable to findings of several other studies.3–5,7,11 Gertszen et al.1 
concluded that nucleoplasty appears to improve overall quality of life. They 
reported improvement in patients’ strength and function after nucleoplasty, even 
after recurrence of pain. Although there is a lack of preprocedure quality of life and 
function scores, postprocedure scores of the SF-36 and NDI showed a normal 
quality of life and low neck disability percentage in group A.12 According to 
literature, PCN is an effective and safe procedure. Our study confirms these main 
findings with long-term follow-up. 
Ideal selection of patients is thought to be an element for successful 
nucleoplasty.3,6 Patients with single-level incomplete annular tears and minimally 
degenerated disks can be expected to benefit most.6 Patients were divided into 2 
groups based on completeness of selection criteria. Patients in Group B had a 
wider range of indications and were believed to have more complex disk 
pathologies, in which a significant longer duration of pain might play a role. 
Comparing the long-term results after PCN of Group A with B, significant 
differences were found for some variables. Group B had a lower satisfaction score 
(55.5 ± 31.4), higher percentage (74%) of patients still using any medication 
postoperatively, and worse physical functioning (PCS = 37.3 ± 12.0). As there is a 
lack of studies focusing on selection criteria, it is difficult to compare these results; 
however, they confirm the recommendations in other studies.3,6 Although physical 
scores were negatively correlated, indicating that a higher neck disability (NDI) is 
accompanied by a lower general physical function (PCS), the NDI only showed a 
negative trend toward group B. As the SF-36 is not a neck-specific questionnaire 
unlike the NDI, the results suggest that other not-specified physical issues restrict 
the quality of life of patients in Group B. According to the SF-36 scoring 
interpretation, the PCS score in Group B was far below the norm.12 Percentages of 
stable or increased pain medication use were higher in Group B accompanied with 
a lower percentage of decrease or without any medication at all. Combined with the 
low PCS score, it might be a plausible explanation for the lower postoperative 
satisfaction in group B. This is confirmed by Galloway, et al.,13 stating that quality of 
life depends on pain relief, which is linked to patient satisfaction. Although lacking 
evidence, the amount of pain medication is assumed to lower the actual pain 
scores in Group B, resulting in a clear trend of better pain scores in group A, but 
not significantly. PCN appeared to be a safe procedure, even regardless ideal 
selection. However, our results justify the recommendation of ideal selection 
settings for successful treatment. 
Several techniques are used in the treatment for cervical disk herniation.5 In the 
past, conventional cervical discectomy was considered the standard treatment.11,14 
The current evolution in spinal surgery has been toward less-invasive 
percutaneous techniques.1,5,14 Nucleoplasty and PRF are important options, with 
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nucleoplasty most often applied.15 Gebremariam et al.16 concluded that no 
equivocal evidence for the superiority of one particular treatment exists. In general, 
cervical discectomy has been developed as an effective treatment for soft cervical 
disk herniation. It has, however, many possible drawbacks such as damage to 
adjacent tissue, chronic loading to adjacent disks resulting in damage and 
transformation, and a long recovery period.3,5 PRF is considered as a useful 
alternative to nucleoplasty. It is safely used in a variety of conditions. Nonetheless, 
its efficacy needs to be investigated.17–19 As research already showed high efficacy 
and safety of PCN with short and mid-term follow-up, this technique is preferred 
until remaining questions regarding PRF are answered.17 
Strong points of our study are very strict group allocation criteria, a large number of 
procedures, and a long follow-up. Our findings confirm that careful indication-based 
patient selection is necessary to achieve better outcomes.3,6 Due to the 
retrospective study design, the lack of a control group, and the lost to follow-up, our 
findings need to be interpreted cautiously.  
We demonstrated the long-term effectiveness and safety of PCN for patients with a 
one-level contained cervical herniated disk in whom conservative treatment has 
failed. Furthermore, the importance of ideal selection settings was shown. Our 
findings should be confirmed in a prospective randomized clinical trial. 
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Abstract 
Background: Although percutaneous cervical nucleoplasty (PCN) has been shown 
to be both safe and effective, its application is still debated. PCN applied in disk 
herniation has not been systematically reviewed before, resulting in a limited 
insight into its effectiveness and safety, and the quality of available evidence. 
Therefore, we systematically reviewed the evidence on the efficacy and safety of 
PCN in patients with a (contained) herniated disk. 
Methods: MEDLINE, EMBASE, and the Cochrane Library (Central Register of 
Controlled Trials) were searched for randomized controlled trials (RCTs) and 
nonrandomized studies using the following keywords: “Nucleoplasty,” “Cervical,” 
“Hernia,” “Herniation,” “Prolapse,” “Protrusion,” “Intervertebral disk,” and 
“Percutaneous disk decompression.” First, all articles were appraised for 
methodological quality, and then, RCTs were graded for the level of evidence 
according a best-evidence synthesis, because a meta-analysis was not possible. 
Finally, the RCTs’ applicability and clinical relevance also was assessed. 
Results: Of 75 identified abstracts, 10 full-text articles were included (3 RCTs and 
7 nonrandomized studies). These studies represented a total of 1021 patients: 823 
patients (≥ 892 disks) were treated by PCN. All studies showed low methodological 
quality, except for two. The level of evidence of the RCTs was graded as moderate, 
with low to moderate applicability and clinical relevance. 
Conclusion: All included studies showed PCN to be an effective and safe 
procedure in the treatment of (contained) herniated disks at short-, mid-, and long-
term follow-up. However, the level of evidence is moderate and shows only low to 
moderate applicability and clinical relevance.  
Introduction 
Rationale 
Disk pathology is an important cause of suffering and disability in the adult 
population, forming a difficult and costly health care issue.1,2 Approximately, 1 
person in 1000 suffers from cervical radicular pain.3,4 Treatment options range from 
conservative to surgical.5 After the exclusion of red flags (ie, cervical myelopathy, 
cervical fracture or instability, and cervical cancer) conventional treatment of 
cervical disk herniation starts with conservative care (CC) (rest, physiotherapy, and 
oral medications). Once conservative treatment has failed, different percutaneous, 
minimally invasive (radiological) procedures can relieve pain, avoiding surgery.1 
These procedures aim at relieving pressure or chemical irritation on sensory 
structures while minimizing trauma to normal tissues, thereby enhancing patient 
recovery.6–8  
Percutaneous cervical nucleoplasty (PCN) is the most often applied technique for 
cervical disk decompression using Coblation technology.1,8 The Coblation 
technology provides simple, efficient disk decompression, because of controlled 
and highly localized ablation, resulting in minimal damage to surrounding healthy 
tissue.2,8–11 Several published studies have demonstrated PCN to be both safe and 
effective, but its application is still debated.1,6–10,12,13 PCN applied in disk herniation 
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has not been systematically reviewed before, resulting in a limited insight into its 
effectiveness and safety, and the quality of available evidence.5  
Objectives 
The aim of this study is to systematically review the evidence on the efficacy and 
safety of PCN in patients with a (contained) herniated disk. 
Methods 
Due to the study design, this study was granted exemption by the local institutional 
review board. 
Protocol and Registration 
A review protocol was written and registered in the PROSPERO database 
(registration number: CRD42012002464), see: 
http://www.crd.york.ac.uk/PROSPERO. 
Eligibility Criteria 
First, randomized controlled trials (RCTs) were searched; however, as only 3 
studies focusing on PCN were eligible the search was extended.14 Hereafter, both 
RCTs and nonrandomized studies were identified. Only studies reporting their 
methods in detail, the number of patients treated, and the efficacy, complications, 
and follow-up (FU) term, with full text available, published from 2000 onwards, 
involving noncadaveric humans of age 18+ and regardless gender or race, were 
included.  
Information Sources 
MEDLINE, EMBASE, and the Cochrane Library (Central Register of Controlled 
Trials), respectively, were searched finally on 07 March 2013. Systematic reviews 
were checked for any missed studies, and reference lists of included studies were 
hand searched. 
Search 
The following keywords were included in the literature search: “Nucleoplasty,” 
“Cervical,” “Hernia,” “Herniation,” “Prolapse,” “Protrusion,” “Intervertebral disk,” and 
“Percutaneous disk decompression”. The complete search is available on request. 
Study Selection 
Identified abstracts were first checked for duplicate studies by 1 reviewer (JW), 
before 2 independent reviewers (JW, WH) screened all abstracts for eligibility. In 
case of disagreement, a third reviewer was consulted (WvdW). Next, the full text of 
the included abstracts were retrieved and assessed for eligibility by 2 independent 
reviewers (JW, WH). Again, a third reviewer was consulted in case of 
disagreement (WvdW). Finally, studies appraised as positive were included. 
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Data Collection Process 
Data extraction was independently carried out by 2 reviewers (JW, WH). Whenever 
they disagreed, a third independent reviewer was consulted (WvdW). 
Data Items 
Before data retrieval, a study data template was designed containing the following 
variables: study design, number of patients, number of treated disks with PCN, 
alternative treatment, main effectiveness parameter(s), FU term (short term: ≤ 3 
months, midterm: > 3 to ≤ 6 months, long term: > 6 months), number of reported 
lost to FU, number of reported complications, and final study result. 
Risk of Bias in Individual Studies 
To assess methodological quality, the risk of bias in individual studies was 
appraised. As both RCTs and nonrandomized studies were included, separate 
analyses were performed. RCTs were appraised using RevMan 5 (Review 
Manager (RevMan) [Computer program] Version 5.2. Copenhagen, The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2012), including judgment on 
random sequence generation, allocation concealment, blinding of participants and 
personnel, blinding of outcome assessment, incomplete outcome data, selective 
reporting and other bias. Each item scored either low or high risk for bias. When an 
item was not reported in the article, it was assumed to have a high risk for bias. 
Based on the method described by Furlan et al.,14 studies were considered high 
quality if at least 4 items scored low risk for bias. In case at least 4 items scored 
high risk for bias, low quality was indicated.14 Nonrandomized studies were 
appraised using the Newcastle-Ottawa Scale (NOS) 
http://ims.cochrane.org/revman/about-revman-5. It scores 3 broad perspectives: 
the selection of the study groups (4 points maximum), the comparability of the 
groups (2 points maximum), and the ascertainment of the outcome of interest 
(maximum 3). As study quality resulting NOS-scoring has not been clearly defined, 
high quality was indicated with a NOSscore of ≥ 7 points and scoring on all 3 
categories at least. Otherwise, the study quality was low. 
Summary Measures 
Due to the clinical heterogeneity between the included studies, it was not possible 
to pool the results. Therefore, a best-evidence synthesis was used to summarize 
the results.5,15 
Synthesis of Results 
For the best-evidence analysis, included studies were split up: RCTs were included 
in the primary analysis, while nonrandomized studies were analyzed separately 
and discussed later with the results from the primary analysis. The level of 
evidence of the included RCTs was appraised using a grading system as described 
by Gebremariam et al.5  
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Risk of Bias across Studies  
To appraise the level of evidence of the included RCTs, a grading system 
proposed by Gebremariam et al.5 was used. This system ranks and divides 
evidence into the following levels:  
 Strong evidence for effectiveness: consistent (ie, at least 75% of the RCTs 
report the same findings) positive (significant) findings within multiple high-
quality RCTs. 
 Moderate evidence for effectiveness: consistent positive (significant) findings 
within multiple low-quality RCTs and/or 1 high-quality RCT. 
 Limited evidence for effectiveness: positive (significant) findings within 1 low-
quality RCT. 
 Conflicting evidence for effectiveness: provided by conflicting (significant) 
findings in the RCTs (< 75% of the studies reported consistent findings). 
 No evidence found for effectiveness of the intervention: RCT(s) available, but 
no (significant) differences between intervention and control groups were 
reported. 
 No systematic review or RCT found. 
Additional Analyses 
As an additional analysis, the applicability and clinical relevance of the results of 
the included RCTs were assessed by 1 reviewer (JW) and validated by another 
(WH).14 In case of disagreement, a third independent reviewer was consulted 
(WvdW). To determine whether study results were applicable and clinically 
relevant, 40 items were assessed per study, as described in the original article of 
Malmivaara et al.16 
Results 
Study Selection 
Seventy-four abstracts were identified through database searching, and 1 
additional abstract was identified by hand search. From these seventy-five 
abstracts, fifty-nine were unique studies of which forty-nine were excluded for not 
meeting our criteria. A PRISMA flow diagram for study selection is shown in figure 
1. 
Study Characteristics 
Fifty-nine abstracts were screened of which ten full-tekst articles were included (3 
RCTs, 7 nonrandomized studies). These ten studies represent a total of 1021 
patients: 823 patients (≥ 892 disks) were treated by PCN (both reports of Cesaroni 
et al.17,18 did not report the exact number and levels of treated disks, but only 
patients n = 62 and n = 349). When distracting the number of patients reported by 
Cesaroni et al.17,18 (62 + 349 = 411), 481 (≥ 892 to 411) detailed PCN treated disks 
remain. Of these, 353 were single level, 49 were at 2 adjacent levels, and 10 were 
at 3 adjacent levels. The C3–C4 level was treated in 33 cases, the C4–C5 level in 
93 cases, the C5–C6 level in 219 cases and the C6–C7 level in 136 cases. Four 
comparative studies were included; 3 RCTs and 1 retrospective study.7,10,17,19 All 
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RCTs10,18,20 compared PCN with CC (medical and/or physical therapy) (n = 103), 
while the retrospective study 7 compared with percutaneous cervical diskectomy 
(PCD) (n = 95). Total FU term ranged between 60 days and 60 months. Treatment 
efficacy was measured using multiple outcome scores, that is, Visual Analog Scale 
(VAS) score for pain, Neck Disability Index (NDI), Short Form 36 (SF-36), Modified 
Macnab criteria. The VAS score for pain was the only outcome measure used in all 
studies, except for one. However, it was not used in a consistent manner. An 
overview of the study characteristics is presented in Table 1. 
Risk of Bias within Studies 
Considering the method used for appraising the risk of bias within studies, all 
studies had a high risk of bias resulting in a low methodological quality, except 
two.7,17 See Tables 2 and 3.  
Results of Individual Studies 
RCTs. A study by Nardi et al.19 showed complete resolution of symptoms in 80% of 
all cases (n = 50) at 60 days after nucleoplasty compared with only 20% in the 
control group (CC, n = 20). Ten percent had no complete amelioration and 
remained under clinical FU with a wait-and-see prospective. The remaining 10% 
without any clinical improvement were treated with alternative traditional methods. 
Patients with complete resolution of symptoms returned to work after 21 days on 
average (range 15 to 36). Patients of the control group returned to work after 46 
days (range 25 to 50). No complications were observed during the study. Overall, 
at short term, the nucleoplasty group significantly improved from baseline (P ≤ 
0.001), unlike the control group (P = 0.172). This study was appraised to be of low 
methodological quality. 
Birnbaum10 compared 26 PCN patients with a CC group (n = 30). The pain scores 
(VAS) in the PCN group were 8.8 (pre-operatively), 2.0 (3 months), 2.7 (6 months), 
and 2.3 (24 months), respectively. In the control group (n = 30), the VAS pain score 
improved from 8.4 (pre-operatively) to 5.1 (24 months). All patients in the PCN 
group returned to work between 24 hours and 2 weeks, with an average 
postoperative recovery period of 8 days. No complications were observed during 
the study. Although no statistical analyses were performed within this study, 
nucleoplasty showed lower VAS pain scores compared with conservative treatment 
at short-, mid-, and long-term FU. The methodological quality of this study was also 
low.  
Cesaroni et al.17 compared 62 patients treated with PCN to a CC group (n = 58). 
Main outcome measures were VAS pain score, NDI, and SF-36 quality of life 
score. The PCN group had significant lower VAS pain scores at all FU time points 
(P < 0.0001). The NDI also improved significantly at 6 weeks (P < 0.0001) and 1 
year FU (P = 0.005), and correspondingly, the SF-36 physical component summary 
(PCS) improved significantly at 6 weeks (P = 0.004), 3 months (P = 0.0237), and 1 
year FU (P = 0.0003). Moreover, a statistically higher percentage of PCN patients 
achieved the minimal clinically important difference (MCID) for VAS pain scores at 
6 weeks (P < 0.0001), 3 months (P = 0.01), and 1 year FU (P = 0.0003), and for 
NDI scores only at final FU (P = 0.002) (Table 4). No complications were observed 
during the study. Overall, the statistical analyses favor nucleoplasty, mainly at 
71 
short- and longterm FU. This study was appraised to be of high methodological 
quality. 
 
 
 
Figure 1. PRISMA flow diagram of the study selection 
 
 
74 abstracts identified through 
database searching 
1 additional abstract identified 
through other sources 
10 studies included in 
qualitative synthesis 
59 abstracts screened 
0 full-text articles 
excluded, with 
reasons 
10 full-text articles 
assessed for eligibility 
49 abstracts excluded; 
no nucleoplasty study 
0 studies included in 
quantitative synthesis 
(meta-analysis) 
16 duplicate abstracts 
removed 
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Table 1. Overview of the Study Characteristics 
Author(s), 
Year 
Study 
design 
Treatment 
 
Number of 
patients 
 
Number of 
treated 
disk by PCN 
FU term 
Nardi 
et al., 
200519 
 
RCT  PCN vs. CC 70 (50 PCN / 
20 CC) 
 
54 (46 unilevel, 4 
multilevel/C4–C5, 
(12) C5–C6 (33), 
C6–C7 (9)) 
 
Up to 60 days 
postoperatively 
 
Birnbaum, 
200910 
RCT PCN vs. CC 56 (26 PCN / 
30 CC) 
 
29 (23 unilevel, 3 
multilevel/C4–C5, 
(8) C5–C6, 
(19) C6–C7 (2)) 
 
Preoperative, 1 day 
(only PCN group), 
1 week, 1, 3, 6, 12, 
and 24 months 
postoperatively 
Cesaroni 
et al., 
201017 
 
 RCT PCN vs. CC 115 (62 PCN / 
53 CC) 
 
≥ 62, Not reported Preoperative, 
6 weeks, 3, 6, 
and 12 months 
postoperatively 
 
Slipman 
et al. 
200320 
 
Uncontrolled 
prospective 
case series 
 
PCN 5 (all PCN) 5 (5 unilevel /C4–
C5, 
(1) C5–C6, (2) 
C6–C7 (2)) 
 
Preoperative, 2, 4, 
6 weeks, 3, and 
6 months 
postoperatively 
 
Bonaldi 
et al., 
200621 
 
Uncontrolled 
prospective 
case series 
 
PCN 55 (all PCN) 75 (36 unilevel, 19 
multilevel/C4–C5, 
(5) C5–C6 (37), 
C6–C7 (33)) 
 
FU period 2 to 
29 months, with 
results presented at 
2 and 6 months FU 
 
Li et al., 
20089 
 
Uncontrolled 
prospective 
case series 
 
 PCN 126 (all PCN) 126 (126 unilevel / 
C3–C4, (21) C4–
C5 
(30), C5–C6 (40), 
C6–C7 (35)) 
 
Preoperative, 
2 weeks, 1, 3, 6, 
and 12 months 
postoperatively 
 
Azzazi 
et al., 
201022 
 
Uncontrolled 
prospective 
study 
 
PCN 47 (all PCN) 65 (30 unilevel, 17 
multilevel/C4–C5, 
(14) C5–C6 (44), 
C6–C7 (7)) 
 
Preoperative, 1, 3, 
6, 12, and 24 
months 
postoperatively  
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Table 1, continued 
Author(s), 
Year 
FU term Reported 
complications 
 
Main outcome 
measure(s) 
Study result(s)/Conclusion 
 
Nardi 
et al., 
200519 
 
Up to 60 days 
postoperatively 
 
No complications 
were 
observed 
 
VAS pain score 
diverted to good, 
poor and no 
result 
(percentages) 
 
Significant improvement in 
percentage of patients treated 
with PCN (P ≤ 0.001), while 
clinical resolution in the CC 
group was not always reached 
(P = 0.172) 
Birnbaum, 
200910 
Preoperative, 1 day 
(only PCN group), 
1 week, 1, 3, 6, 12, 
and 24 months 
postoperatively 
No complications 
were 
observed 
 
VAS pain score  PCN showed better results 
than the continuation of CC 
 
Cesaroni 
et al., 
201017 
 
Preoperative, 
6 weeks, 3, 6, 
and 12 months 
postoperatively 
 
No complications 
were 
observed 
 
VAS pain score; 
NDI; 
MCID based on 
VAS 
and NDI scores; 
SF-36 
PCN offers improved pain relief 
as well as superior immediate 
and long-term gains in 
functional ability and quality 
of life when compared to CC 
 
Slipman 
et al. 
200320 
 
Preoperative, 2, 4, 
6 weeks, 3, and 
6 months 
postoperatively 
 
Not reported VAS pain score; 
Medication 
usage; 
Return to work 
rate 
 
 
More than 75% reduction in 
VAS pain score was found at 
all FU intervals for each 
subject; 4 patients returned to 
work full time within 2 weeks, 
the fifth had secured early 
retirement 
Bonaldi 
et al., 
200621 
 
FU period 2 to 
29 months, with 
results presented at 
2 and 6 months FU 
 
One case of 
infectious diskitis 
(treated 
successfully, but 
poor clinical 
outcome); One 
case with broken 
tip remained in 
disk space, 
asymptomatic 
during 
> 2 years 
Modified 
Macnab 
criteria 
 
PCN appeared to be a 
minimally invasive low-risk 
approach, which is easy to 
perform, associated with only 
minimal discomfort to the 
patient, and effective on the 
short-term 
 
Li et al., 
20089 
 
Preoperative, 
2 weeks, 1, 3, 6, 
and 12 months 
postoperatively 
 
One case with 
broken tip 
remained in disk 
space, but 
asymptomatic 
 
VAS pain score; 
Modified 
Macnab 
criteria 
 
PCN was shown to be an 
efficacious minimally invasive 
technique for the treatment 
of symptoms associated with 
contained cervical herniated 
disk 
Azzazi 
et al., 
201022 
 
Preoperative, 1, 3, 6, 
12, and 24 months 
postoperatively 
 
One case of 
diskitis (treated 
successfully, but 
persistent 
pain); One case 
with broken 
tip remained in 
disk space, 
but asymptomatic 
VAS pain score; 
NDI 
The use of PCN for the 
treatment of intradiskal 
herniation provided 
encouraging results 
owing to low morbidity and 
good clinical outcome soon 
after the procedure 
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Table 2. Methodological Quality of the RCTs 
References 
 
Random 
sequence 
generation 
(selection 
bias) 
 
Allocation 
concealment 
(selection 
bias) 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
 
Blinding of 
outcome 
assessment 
(detection bias) 
 
Incomplete 
outcome data 
(attrition bias) 
 
Selective 
reporting 
(reporting bias) 
Other bias 
 
Nardi et al.,200519 - - -  - + + - 
Birnbaum 2009 10 - - -  - + + - 
Cesaroni et al.,201017 + + -  - + + - 
- high risk of bias; +, low risk of bias. 
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Table 3. Methodological Quality of the Nonrandomized Studies 
 
 Selection  Comparability  Outcome 
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Slipman, et al. 2003 (21) - - + +  - -  + + + 
Bonaldi, et al. 2006 (22) + - + +  - -  + + + 
Li, et al. 2008 (9) + - + +  - -  + + - 
Azzazi, et al. 2010 (23) + - + +  - -  + + - 
Yan, et al. 2010 (7) + + + +  + -  + + + 
Cesaroni, et al. 2011 (19) - - + +  - -  - + + 
Sim, et al. 2011 (12) + - + +  - -  + + + 
-, high risk of bias; +, low risk of bias. 
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Table 4. Statistical Outcomes of Cesaroni et al.17 Comparing PCN and CC per FU 
Clinical outcome 6 weeks FU 3 months FU 6 months FU  1 year FU 
VAS pain score P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001 
NDI P < 0.0001 NS NS P = 0.005 
SF-36 (PCS) P = 0.004 P = 0.0237 NS P = 0.0003 
VAS MCID P < 0.0001 P = 0.01 NS P = 0.0003 
NDI MCID NS NS NS P = 0.002 
FU, follow-up; MCID, minimal clinically important difference; NDI, neck disability index; NS, not 
significant; SF-36 (PCS), short form-36 (physical component summary); VAS, visual analogue scale.  
All significant outcomes favor PCN over CC. 
 
 
Nonrandomized Studies. Slipman et al.20 reported results from 5 patients after 
PCN. The VAS pain score was reduced more than 75% at all FU intervals (2, 4, 
and 6 weeks, 3 and 6 months postprocedure) for each subject. Four of 5 patients 
returned to full-time work within 2 weeks. No statistical analysis was performed; 
however, the results suggest that PCN may lead to rapid and prolonged pain relief 
at short- and mid-term in patients with cervical radicular pain due to an acute focal 
protrusion. The methodological quality of this study was low. 
Bonaldi et al.21 showed good to excellent outcomes (Modified Macnab criteria) in 
80% of the 55 patients suffering from cervical soft disk protrusion at 2 months FU. 
The success rate increased even further at 6 months to 85%. One clinically 
relevant complication of diskitis was reported but treated successfully. In another 
patient, there was an in situ rupture of the device tip; however, this patient 
remained asymptomatic. According to this study, PCN appears to be an effective 
and safe treatment at short- and mid-term. The methodological quality of this study 
was also low.  
Li et al.9 evaluated the prospective results of 126 PCN procedures for contained 
cervical disk herniation at 2 weeks, 1-, 3-, 6-, and 12-month FU. The VAS pain 
scores improved statistically (P < 0.01) for all FUs (range 2.42 ± 0.71 to 2.44 ± 
0.71) compared with preoperative findings (7.25 ± 0.44). The rate of excellent and 
good results based on the modified Macnab criteria was 81.7%. Besides a 
technical complication (broken device tip) that was asymptomatic, no complications 
were reported. This study shows PCN to be safe and effective at short-, mid-, and 
long-term FU. The methodological quality of this study was appraised to be low. 
Azzazi et al.22 assessed the safety and clinical outcome after PCN in 47 patients 
with contained disk herniation or focal protrusion at 1, 3, 6, 12, and 24 months FU. 
The VAS pain score decreased statistically (P = 0.001) from 8.1 ± 1.4 pre-
operatively to a VAS pain score between 0.6 ± 0.5 to 1.1 ± 0.9 postoperatively. 
Complete resolution of symptoms (VAS < 2.0) was found in 72% (1 month), 83% (3 
months), 79% (6, 12, and 24 months). The NDI improved statistically (P = 0.001) 
from 80.5 ± 4.4 preoperatively to a NDI score between 4.2 ± 3.8 to 12.6 ± 8.1 
postoperatively. Significant improvement based on the NDI was found in 63.8% of 
the patients at 1 month, 76.6% at 3 months, and 80.6% at 6 to 24 months. One 
postoperative complication was reported (diskitis) and treated, but pain persisted. 
Also, an intra-operative complication (broken device tip) occurred in another 
patient; however, this patient was asymptomatic. The study concludes that PCN in 
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patients with contained disk herniation or focal protrusion is safe and effective at 
short-, mid-, and long term. The methodological quality of this study was low. 
Yan et al.7 retrospectively compared clinical outcomes of 176 patients with 
symptomatic contained cervical disk herniation treated with PCN (n = 81) or PCD 
(n = 95) at a FU of 16–48 months. In the PCN group, the VAS pain score improved 
from 7.12 ± 1.13 to 2.74 ± 0.89 (P < 0.001) compared with 7.18 ± 1.09 to 2.71 ± 
0.91 (P < 0.001) in the PCD group. There was no difference found in success rates 
(Modified Macnab criteria scoring excellent or good) between both groups, 
respectively, 77.8% (PCN) and 79.5% (PCD). A technical complication (broken 
device tip) occurred in 1 patient, but this person remained asymptomatic. One case 
of diskitis was reported within the PCD group. The results show that both methods 
are safe and have good long-term clinical outcomes. This study was of high 
methodological quality. 
Cesaroni et al.18 evaluated clinical outcomes of 349 patients with contained 
herniated cervical disk or focal protrusion treated by PCN. Outcomes were 
assessed immediately postoperatively at 3 months and then every year up to 5 
years. At all time points, 50% to 60% of the patients had good results, 30% to 40% 
satisfactory results, and 5% to 10% showed no change. One postoperative 
complication occurred (diskitis), but the patient was treated successfully. This study 
shows PCN to be effective and safe in patients with contained herniated cervical 
disk or focal protrusion at short- and long-term FU. The methodological quality of 
this study was appraised to be low. 
Finally, Simet al.12 assessed the efficacy of PCN in 22 patients with cervical disk 
disorders. The VAS pain score decreased significantly (P < 0.05) from 9.3 ± 0.9 
(preprocedure) to 3.7 ± 2.1 (1-month postoperative) and 3.4 ± 2.3 (6 months 
postoperative). Patient satisfaction (Modified Macnab criteria) at 6 months was 
good to excellent in 76% of the patients, fair in 14%, poor in 5%, and worse in 5%. 
No complications were observed. The study results demonstrate PCN to be a safe 
treatment of cervical disk disorder with good shortand mid-term clinical outcomes. 
The methodological quality of this study was low. 
Synthesis of Results 
A best-evidence synthesis was performed, because metaanalysis was not possible 
due to clinical heterogeneity between the included studies in this systematic 
review.  
Risk of Bias Across Studies 
Following the best-evidence synthesis, the level of evidence for the efficacy and 
safety of PCN in patients with a herniated disk, when compared to CC at short-, 
mid-, and long-term FU, appeared to be moderate in the included RCTs.  
Additional Analysis 
The appraisal of applicability and clinical relevance of the study results, as 
suggested by Malmivaara et al.,16 showed differences between the 3 RCTs. Two 
studies10,19 had a low applicability and clinical relevance, mainly due to a poorly 
described study population, control intervention, cointerventions, outcome 
measures, and analyses. The third study17 showed moderate applicability and 
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clinical relevance, because information about the control intervention and 
cointerventions lacked (Table 5). 
Discussion 
Summary of Evidence 
Three RCTs (n = 241) focusing on treatment of patients with a herniated disk were 
included in the primary analysis of this systematic review.10,17,19 Two studies10,19 
had low methodological quality, due to a high risk of selection, performance, and 
detection bias. All 3 compared nucleoplasty (n = 138) with conservative treatment 
(n = 103) and showed better results for PCN at short-, mid-, and long term. This 
finding needs to be interpreted cautiously because of the moderate quality of 
evidence, and low to moderate applicability, and clinical relevance of the study 
results. 
As the number of available RCTs was very limited, nonrandomized studies were 
also included to broaden the extent of evidence on the efficacy and safety of PCN 
in patients with a herniated disk. Seven nonrandomized studies (n = 780) were 
included, reporting ≥ 747 disks treated by PCN.7,9,12,18,20–22 Although 6 out of 7 had 
a high risk of bias, all 7 concluded that PCN was effective and safe for the 
treatment of a cervical herniated disk, thereby confirming the short-, mid-, and long-
term results found in the primary analysis of RCTs. According to the 
nonrandomized studies, satisfactory or good to excellent results were found in ≥ 
77.3% of the treated patients at final FU ranging from 6 to 60 months.7,9,12,18,20–22 
VAS pain scores decreased from 7.1 to 9.3 pre-operatively to 2.4 at 3 months, 2.4 
to 3.4 at 6 months, 2.4 at 12 months, and 2.7 at 16 to 48 months.7,9,12 The NDI 
significantly improved in 63.8% of the patients at 1 month and 76.6% at 3 months 
FU.22 
For the safety assessment of PCN, it is important to evaluate as much treated 
disks as possible. In this review, the total of both the RCTs (≥ 145) and 
nonrandomized studies (≥ 747) is ≥ 892. As complications were not explicitly 
reported in all studies, 1 study was excluded,20 remaining ≥ 887 PCN treated 
disks. Besides observed local anesthetic-related side effects, soreness at the 
needle insertion site, new numbness and tingling, increased intensity of 
preprocedure pain and new areas of pain, 4 cases of diskitis were reported.7,18,21,22 
These complications were treated successfully in 3 patients. The treatment results 
of 1 complication were not reported. Four successfully treated cases reported a 
broken tip of the device that remained in the intervertebral disk, without causing 
any complications.7,9,21,22 Although this number is very low, it should be considered 
an avoidable complication by improving used materials. 
Based on these figures, PCN seems to be a safe technique.  
  
79 
Table 5. Appraisal of Applicability and Clinical Relevance of the RCTs 
Items Nardi et 
al., 200520 
Birnbaum 
200910 
Cesaroni et 
al., 201018 
 
Methods: Does the report enable the assessment of 
applicability? 
   Study population 
       1 Age  
       2 Gender  
       3 Setting  
       4 Type of disease/disorder  
       5 Duration of disease/disorder  
       6 Severity of disease/disorder  
       7 Recruitment procedure  
       8 Description of inclusion and exclusion criteria  
 
 
- 
- 
- 
+ 
+ 
+/- 
- 
+ 
 
 
+ 
+ 
- 
+ 
+ 
+ 
- 
+/- 
 
 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
   Index intervention 
        9 Type/content 
      10 Intensity/dosage  
      11 Frequency  
      12 Duration  
      13 Experience of provider  
      14 Proper intervention to answer the research question 
 
+ 
+ 
+ 
+ 
- 
+ 
 
+ 
+ 
+ 
+ 
- 
+ 
 
+ 
+/- 
+ 
+ 
- 
+ 
   Comparator (control intervention) 
      15 Type/content  
      16 Intensity/dosage   
      17 Frequency  
      18 Duration  
      19 Experience of provider  
      20 Proper intervention to answer the research question  
 
+ 
+/- 
+/- 
+/- 
- 
+ 
 
+ 
- 
- 
- 
- 
+/- 
 
+ 
- 
- 
- 
- 
+ 
   Cointerventions per study group 
      21 Type/content  
      22 Intensity/dosage  
      23 Frequency  
      24 Duration  
      25 Experience of provider  
 
+/- 
- 
- 
- 
- 
 
+/- 
+/- 
- 
- 
- 
 
+ 
- 
- 
- 
- 
   Outcome measures 
      26 Main symptom, disease-specific disability, and generic 
           disability  
      27 Validity and reliability of instruments  
      28 Follow-up moment  
      29 All potential adverse effects  
 
+/- 
+/- 
+ 
+/- 
 
+/- 
+/- 
+ 
+/- 
 
+ 
+ 
+ 
- 
   Analysis 
      30 Intention-to-treat analysis  
      31 Confounding considered  
      32 Effect modification considered  
      33 Economic evaluation  
 
- 
- 
- 
- 
 
- 
+/- 
+/- 
- 
 
+ 
+ 
+ 
- 
Results: Are the study results clinically relevant? 
      34 Baseline values of main symptoms and disability plus      
            measure of variance  
      35 Adherence in all study groups  
      36 Dropout rate  
      37 Follow-up values of main symptoms and disability plus  
           measure of variance  
      38 Confidence intervals of between-group differences  
      39 Magnitude of difference between groups  
      40 Incidence of all adverse  
 
- 
+ 
+ 
- 
- 
- 
+ 
 
+/- 
+/- 
+ 
+/- 
- 
+/- 
- 
 
- 
- 
+ 
+ 
- 
+ 
+ 
- no; + yes; +/- not clear. 
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As available literature on PCN-treating disk herniations is limited, we also 
compared reported results with the most recent systematic review on the 
effectiveness of lumbar nucleoplasty for treating contained disk herniation.8 They 
found VAS pain scores at baseline of ± 7.1 and ± 4.0 at 1, 3, 6, and 12 months FU. 
Successful outcomes, defined as more than 50% pain relief or a 2-point reduction 
on VAS, were found in 62.1% of the patients on average (range 6.25% to 84%).8 
No major complications were reported related to nucleoplasty.8 Based on these 
figures, safety is comparable, but PCN seems to be more effective, as already 
proposed by Sim et al.12 However, a clear explanation is lacking, and the quality of 
evidence in the analyzed studies was moderate.12 
An important factor in the success rate of nucleoplasty lies in its technique. The 
basic mechanism of percutaneous disk decompression has been well understood. 
The removal of approximately 1 mL of disk tissue volume, corresponds to a diskal 
volume reduction of about 10% to 20% and a disproportionately large fall (> 95%) 
in intradiskal pressure,7–9,23–25 which in turn reduces some chemical and 
mechanical factors causing pain.8 However, several techniques exist, and each 
method has its own limitations like removal of too much tissue, indiscriminate 
removal of tissue, thermal injury to the disk or aggressive access into the 
disk.10,12,26 Nucleoplasty using Coblation technology claims to be not affected by 
these limitations. It removes a portion of the nucleus tissue using a one-millimeter-
diameter bipolar instrument that creates radio frequency energy.8 Ablation is 
accomplished with a low-temperature (typically 40 to 70°C) plasma field of ionized 
particles, rather than heat.2,8,11,25,26 These particles have sufficient energy to break 
down organic molecular bonds within the tissue, dissolving the soft tissue material 
of the disk nucleus.2,8,11,25 Therefore, the technology provides simple, efficient disk 
decompression, because of controlled and highly localized ablation, resulting in 
minimal damage to surrounding healthy tissue.2,8–11 Considerable studies have also 
noted the importance of application in well-selected cases, mainly resulting from 
the technical background.8,10,12,22 For example, patients with a contained herniated 
disk and minimally degenerated disks confirmed on MRI, who are unresponsive to 
conservative treatment and suffering more arm than axial neck pain.8,10,12 
A meta-analysis was not possible because of clinical heterogeneity between 
studies. The VAS pain score was the main outcome in all trials but used in an 
inconsistent manner. The included studies had different FU terms, number of 
patients treated and, whether or not applicable, different alternative treatment 
courses. Nonetheless, all authors concluded PCN to be a safe, promising, and 
efficacious procedure for symptomatic (contained) disk herniation.7,9,10,12,17–22 
However, the best-evidence synthesis of the analyzed RCTs (study design that 
ranks second highest on the evidence ladder) showed only a moderate quality of 
evidence for the effectiveness of PCN compared with CC at short-, mid-, and long-
term FU. Based on this result, we conclude the effectiveness of PCN in patients 
with a herniated disk to remain uncertain and its application doubted. In addition, 
the included RCTs had only low to moderate applicability and clinical relevance of 
study results, mainly due to poorly described study population, control intervention, 
cointerventions, outcome measures and analysis within their study reports. As a 
result, the transfer of study outcomes to general daily practice is currently limited. 
Therefore, it is not only very important to increase the number of studies 
investigating PCN, but also to improve the methodological quality and level of 
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evidence, and the reporting of RCTs including their results. Besides CC, minimally 
invasive methods (ie, pulsed radiofrequency) should be compared too. 
Limitations 
As PCN in patients with a cervical herniated disk is relatively new and still 
considered controversial, available literature is limited.5,13 Only 3 RCTs and 7 
nonrandomized studies were included. Due to clinical heterogeneity, a meta-
analysis was not possible. However, we were able to discuss and compare the 
analyzed studies and to provide a best-evidence synthesis of the RCTs included in 
the primary analysis,5,16 while appraisal of the applicability and clinical relevance of 
these studies was carried out as a valuable, additional analysis. To improve the 
reporting of our systematic review, the PRISMA statement was used.27 
Conclusions 
All included studies show PCN to be an effective and safe procedure in the 
treatment of (contained) herniated disks at short-, mid-, and long term FU. 
However, the level of evidence is moderate, because the majority of reviewed 
studies have a nonrandomized design, and moreover, the identified RCTs are in 
general of poor methodological quality and show only low to moderate applicability 
and clinical relevance. Although the primary outcomes are promising and the 
application of PCN is encouraged in well-selected cases, more and better-designed 
studies using validated outcome measures are needed. 
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Abstract 
Background: Cervical neck pain is often caused by cervical disk pathology and 
may cause severe symptoms and disability. Surgeons and patients are increasingly 
aware of postsurgery-related complications. This stimulated the clinical usage of 
minimally invasive treatments such as percutaneous nucleoplasty (PCN) and 
pulsed radio frequency (PRF). However, scientific evidence on both treatments is 
limited. 
Objective: Our objective was to evaluate the efficacy of PCN compared to PRF in 
patients with contained cervical disk herniation. 
Methods: A prospective randomized clinical trial was conducted including 34 
patients with radicular pain due to a single contained cervical disk herniation who 
were treated with either PCN or PRF. Demographic data were collected, and the 
Medical Outcomes Study 12-Item Short Form (SF-12) Health Survey, visual analog 
scale (VAS), and the Neck Disability Index (NDI) were completed 1, 2, and 3 
months after treatment. Treatment satisfaction and complications were recorded. 
Results: In the PCN group (n = 17, mean age 52.4 years, 10 female/7 male), 
patients were treated at C5 to C6 (8 cases) or C6 to C7 (9 cases). In the PRF 
group (n = 17, mean age 49.5 years, 8 female/9 male), patients were treated at C3 
to C4 (1 case), C5 to C6 (10 cases), or C6 to C7 (6 cases). At 3 months, mean 
pain VAS improved significantly from baseline in the PCN group (mean 
improvement: 43.4 points) and in the PRF group (34.0 points). However, 
improvement in 1 group was not superior compared to the other group (P = 0.48). 
No serious complications were reported. 
Conclusion: Within 3 months, both PCN and PRF show significant pain 
improvement in patients with contained cervical disk herniation, but none is 
superior to the other. Both treatment options appear to be effective and safe in 
regular clinical practice.  
 
Introduction 
Neck pain caused by cervical disk pathology may cause severe symptoms and 
disability.1 It is also difficult to treat and a costly healthcare issue.2 Approximately 1 
person in 1,000 suffers from cervical radicular pain.3,4 Treatment options are 
conservative at first, but more severe or resistant cases need surgical intervention.5 
Examples of conservative care are rest, physiotherapy, and oral medication. If 
conservative treatment fails, percutaneous, minimally invasive (radiological) 
procedures can be used to relieve pain.1 These procedures work by minimizing 
pressure or chemical irritation on sensory nerves, while at the same time 
minimizing trauma to healthy tissues.6–8 Although different minimally invasive 
treatment modalities are described in the literature, scientific evidence on their 
effectiveness is limited, making it difficult for the clinician to decide which treatment 
modality should be used.3,5 The current trends in spinal surgery are nowadays 
reducing surgery related trauma, increasing patients’ awareness of alternatives to 
surgical procedures and development of new technologies (eg, percutaneous 
nucleoplasty [PCN]). 
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The basic principle of most percutaneous procedures is that a small volume 
reduction in approximately 1 mL in a hydraulic space, such as a healthy spinal disk, 
results in a volume reduction of about 10% to 20%7–9 with a subsequent large 
pressure decrease. This decreased pressure may result in relief of chemical and 
mechanical factors which cause symptoms such as pain and sensory or motor 
function loss.8 PCN is a percutaneous disk decompression (PDD) technique using 
coblation technology (Figure 1A,B).6 With a 1mm diameter bipolar instrument, 
which creates radio frequent energy, a low temperature (typically 40 to 70°C) 
plasma field of ionized particles removes some nucleus tissue.6 These ionized 
particles are able to break down organic molecular bonds thereby dissolving part of 
the disk nucleus.2 While the basic mechanism of percutaneous disk decompression 
(PDD) has been well understood, there are concerns on indiscrete removal or 
removal of too much tissue,10,11 although several studies have shown that PCN is 
both safe and effective.1,6–12 Clinically, PCN is the most often used treatment for 
patients with a herniated cervical disk.1 
Pulsed radio frequency (PRF) treatment of the dorsal root ganglion is also an 
acknowledged pain treatment modality for (cervicogenic) disk pain. It is used as a 
minimally neurodestructive technique, as an alternative to radio frequency heat 
lesions, with significantly fewer complications.13,14 Radiofrequency treatment of the 
cervical dorsal root ganglion (DRG) to treat cervical radicular pain was first 
described by van Kleef et al.,8 but because of reported side effects and the 
possibility of deafferentation pain, PRF is now commonly accepted for cervical 
DRG treatment (Figure 2A,B). Van Zundert et al.3 concluded that PRF treatment 
had significantly better outcomes compared to sham treatment. 
Both PCN and PRF are applied in clinical practice with promising results; however, 
studies comparing the effectiveness of both interventions are lacking.5 In this study, 
we prospectively studied the effectiveness of PCN vs. PRF in patients with a 
contained cervical disk herniation. As PCN is a causal therapy in contrast to the 
symptomatic PRF treatment, we hypothesized that PCN would result in superior 
clinical outcomes compared to PRF. 
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Figure 1. (A) Oblique view of needle entry point with percutaneous nucleoplasty (PCN) treatment (C5 to 
C6 level). (B) Lateral view of needle depth with PCN treatment (C5 to C6 level). 
A 
B 
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Methods 
Patient Population 
In this prospective, randomized controlled study, 38 patients (Table 1) with single-
level contained cervical disk herniation confirmed on prestudy clinical MRI were, 
after providing written informed consent, included and randomized to either 
percutaneous nucleoplasty treatment (PCN group) or pulsed radiofrequency 
treatment (PRF group) (Figure 3). Patients were seen after the neurologist 
diagnosed a disk herniation using MRI and history taking. Our study was approved 
by the Medical Review Board (nr. NL39783.015.12). We included patients with a 
contained, single-level cervical disk herniation diagnosed on recent MRI (< 4 
weeks), who failed conservative treatment and reported radicular pain (≥ 50 mm on 
100 mm Visual Analogue Scale for pain [VAS- 100 mm]) with or without neck pain 
corresponding to the herniated level, and a disk height over 50% of adjacent level. 
No electromyographical examination was performed, but patients who did not 
respond (> 50% temporary pain relief for at least 30 minutes) to a diagnostic nerve 
block15 placed with local anesthetic (Lidocaine 1% 1 mL) at the level identified with 
history taking and MRI (Figure 4A,B) were excluded. Patients with extruded disk 
fragmentation, cervical spondylolisthesis, or spinal canal stenosis and patients with 
previous surgery at the index cervical disk herniaton level were also excluded. All 
remaining patients were consequently randomized. 
Description of the Performed Interventional Techniques 
 
PCN Treatment. Before entering the operating room, 1,000 mL of NaCl solution 
was administered to the patient. Cefazolin (1.0 g) was intravenously injected as 
antibiotic prophylactixis, with continuous vital sign monitoring and oxygen supply at 
5 L/min via nasal prong during the procedure. The procedure was performed under 
local anesthesia, but propofol was administered in increments for sedation. To 
make access into the desired cervical disk possible using the standard rightsided 
anterolateral approach, the patient was placed in a supine position, arms next to 
the body and the neck slightly hyperextended. A chlorhexidine solution was applied 
for disinfecting the anterior neck area including the surrounding skin, and sterilized 
drapes covered the operating area. The percutaneous cervical nucleoplasty 
procedure was performed using C-arm fluoroscopic imaging (Ziehm, Vista, 
Orlando, FL, U.S.A).  
First, the position and angle of the targeted disk were visualized radiographically. 
Anteroposterior and caudal angulation was used to optimally visualize the disk 
space; oblique rotation was used to get a view in which the trachea/esophagus is 
outside the center of the beam. Based on these images, the entry point for the 
needle was marked next to the medial border of the right sternocleidomastoid 
muscle. After marking the entry point, local anesthetic (1% lidocaine) was applied 
in the space between 2 fingers to anesthetize the skin and subcutis. One finger 
was positioned at the lateral border of the trachea and larynx, and the other 
pushed the carotid artery away and pointed toward the vertebral surface. It was 
important to check that no blood was aspirated with repeated suction and injection. 
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To confirm that the needle was introduced correctly, repeated suction and injection 
was used to check there was no aspiration of blood.  
 
B 
Figure 2. (A) Pulsed radio frequency (PRF) treatment C6 level, oblique view of needle positioning. (B) 
PRF treatment C6 level, anterior–posterior (AP) view for needle depth assessment.  
 
 
 
 
 
 
Table 1. Patient Population Characteristics 
A 
B 
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  PCN PRF P 
Male/female  7/10  9/8 0.37 
Mean age (years)   52.4  49.5  0.74 
Duration of symptoms 
(months) 
 11.9  12.1  0.95 
Level of herniated disk  
    
 
C3/4  
C5/6  
C6/7  
0 
8  
9   
1 
10  
6   
n/a 
n/a  
n/a 
PCN, percutaneous nucleoplasty; PRF, pulsed radio frequency. 
 
Next, a 19-gauge trocar 3-inch spine needle (ArthroCare Co., Sunnyvale, CA, 
U.S.A.) was brought to the annulus fibrosis of the herniated disk. C-arm 
fluoroscopic images in anteroposterior, oblique, and lateral planes were made to 
control the direction of the needle in regard to the disk surface and confirm its end 
position. If in the correct position, the stylet was withdrawn and the Perc DC 
SpineWand (ArthroCare Co.) was introduced. After advancing slightly more and 
rechecking the final position, the standard ArthroCare power generator was 
connected. Before starting the procedure, 1 test was executed by coagulation. 
When no pain was remarked by the patient, the procedure could be performed 
safely. A short initial coagulation was performed when the wand was inserted, 
using 3 ablation cycles of 8 seconds each, and rotating the tip of the wand 180° 
when withdrawal was started with the control set at 125 V, causing a 52°C thermal 
reaction.11 After withdrawing the needle slightly, coblation was repeated. Next, the 
trocar was removed and a skin plaster was applied. For the first 2 hours after the 
procedure, patients had to stay in bed in a supine position. They also were 
instructed to wear a cervical brace for 3 days, preventing uncontrolled movements 
of the cervical spine. Patients were discharged with postoperative precaution 
instructions and contact numbers in case of complications. A follow-up visit at the 
outpatient clinic was scheduled 2 months after the procedure. The cervical 
nucleoplasty procedures were offered by 2 different experienced pain physicians. 
 
PRF Treatment. With PRF, the nerve is exposed to a high-frequency electric field 
with a maximal temperature of the electrode tip of 42°C. All PRF treatments were 
performed in the outpatient treatment room. After positioning the patient supine, 
the entry point was located using C-arm fluoroscopy. Next, the skin at the entry 
point was decontaminated using an alcohol swab and a 21-gauge 5-cm long 
Cosman (type CC) needle with a 5-mm active tip was inserted under fluoroscopy. 
An oblique view tunnel vision to the dorsocaudal of the foramen at the treatment 
level was used for optimal needle placement. When correct needle direction was 
confirmed with fluoroscopy, the C-arm was moved to an anterior–posterior (AP) 
view for determining correct needle depth. When both correct direction and depth 
were reached, a 50 Hz sensory stimulus was applied, which was confirmed by the 
patient targeting a 0.4 V. Next, a 2 Hz motor stimulus was used and confirmed by 
the patient to make sure the correct cervical level was targeted. After confirming 
the sensory and motor stimulus, a 45 V, 2 Hz (20 ms) PRF stimulus (maximum of 
42°C) was applied for 6 minutes. After the PRF stimulus was completed, the 
needle was withdrawn and the skin covered with a standard skin plaster. For 
precautions, the patient was observed for 30 minutes before being discharged 
home.  
 92 
 
 
 
Figure 3. Consort 2010 study flow diagram. 
 
Rehabilitation Procedure 
Rehabilitation procedures were equal for both treatment groups. Patients were 
allowed to continue their own medication and gradually return to their previous 
activity level. Within the first 2 days, patients were not allowed to lift anything, to 
bend over, or to drive a car. They were also not allowed to sit for longer than 10 to 
20 minutes or walk longer than 20 minutes continuously. Between day 2 and 14, 
patients were allowed to start with light activities, lifting no more than 5 kg, 
gradually increasing walking distance to 2 times for a half an hour per day. After 1 
week, they were also allowed to start cycling for half an hour maximally. Turning 
the head quickly was prohibited during the first week. Until 2 weeks, swimming or 
being treated by a chiropractor or a manual therapist was not allowed. After 2 to 4 
weeks, patients were allowed to resume their work, to start bending and cervical 
stretching, and to resume swimming. Increasing walking activities to 1 hour 
continuously per day was allowed. However, lifting more than 15 kg was not 
allowed for the first 6 weeks. After 4 weeks, patients were allowed to start their 
rehabilitation program under supervision of a physical therapist. 
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Clinical Follow-up 
Clinical improvement for both treatment groups was assessed with a Visual 
Analogue Scale-100 mm (VAS) for pain change,16 a 4-level item for pain 
improvement and a 4-level item for patient satisfaction combined with a VAS for 
satisfaction. Furthermore, neck and limb functioning and quality of life were 
measured with the Neck Disability Index (NDI) which scores 0 (best) to 50 (worst)17 
and the Short Form 36 (SF-36).18 Also the number, nature, and severity of 
complications, use of pain medication pre- and postoperatively, and recurrence of 
symptoms/cases were recorded. 
Statistical Analyses 
The data are presented as mean ± SD. Outliers were filtered out by checking if all 
data were in the range of mean ± 2 SD. Descriptive statistics were used to present 
the results of the main variables. In case of normal distributed data, a 2-sided 
Student’s t-test for independent samples was used to compare mean VAS pain and 
mean VAS satisfaction. When the between-groups analysis resulted to be 
significant, a post hoc analysis was executed within groups. The level of statistical 
significance was set at P < 0.05. For all statistical analyses SPSS (version 19.0) 
was used.  
The sample size calculation was based on the difference in mean VAS (0 to 100 
mm) scores for pain between groups at 3 months. The minimally clinical important 
difference (MCID) was set at ≥ 20 mm at the last follow-up based upon published 
literature. Power analysis (PS—Power and Sample Size Calculation; Informer 
Technologies Inc., Madrid, Spain), assuming a SD of 15 mm, using a significance 
level of 0.05 and a power of 90% resulted in a sample size of 15 patients per 
group. 
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Figure 4. (A) Oblique view of prognostic blockade C6 to C7. (B) anterior–posterior (AP) view of 
prognostic blockade C6 to C7 with contrast. 
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Results 
Treatment Results 
In both groups, mean VAS pain scores improved at each follow-up time point 
compared to baseline (Figure 5). Eleven patients were lost to follow up. At 3 
months follow-up, mean VAS pain improved 43.4 points in the PCN group vs. 34.0 
points in the PRF group (P = 0.48). Mean VAS pain scores showed more 
improvement in the PCN group compared to the PRF group at each time point, but 
this difference never reached statistical significance (Table 2). There were 65% 
responders in the PCN group (11/17) compared to 53% responders in the PRF 
group (9/17, P = 0.49). Patient satisfaction with treatment results (VAS score) in 
the PCN group was 58.4 compared to 63.5 in the PRF group (P = 0.69).  
Complications 
There were no serious complications, but 3 patients in the PCN group and 3 
patients in the PRF group reported minor side effects. In the PCN group, all 
complications were transient and mostly localized in the neck area, consisting of 
problems with swallowing. In the PCN-treated patients, no postoperative discitis 
occurred. In the PRF group, complications were mainly noticed outside the neck 
region, which consisted of headaches and muscle stiffness, and were also 
transient. All complications were mild in severity. 
  
 
Figure 5. Visual analog scale (VAS) pain results at each follow-up point. 
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Table 2. Main Study Outcomes at Each Follow-Up 
 PCN (n = 17) PRF (n = 17) P 
VAS pain 
   Baseline  
      1M  
      2M  
      3M  
 
71.0 
29.3 
31.5  
27.6  
 
69.5 
41.0  
38.0  
35.5  
 
0.75 
0.26 
0.55 
0.48 
NDI 
   Baseline  
      1M  
      2M 
      3M  
 
21.1 
15.9  
12.3  
11.1  
 
19.4  
14.9  
12.2 
10.8 
 
0.54 
0.84 
0.99 
0.93 
VAS satisfaction 
      1M  
      2M  
      3M 
 
68.9  
67.8  
58.4 
 
52.8  
60.9  
63.5 
 
0.13 
0.55 
0.69 
PCN, percutaneous nucleoplasty; PRF, pulsed radio frequency; VAS, visual analog scale; 
NDI, neck disability index. 
Discussion 
In this study, we compared 2 active treatments (PCN and PRF), rather than a 
placebo control or “usual care” comparison. In this prospective randomized 
controlled trial, there was no significant difference in outcome between PCN and 
PRF treatment for patients with a contained, single-level herniated cervical disk. 
However, with both procedures, VAS pain scores significantly improved after 
treatment compared to VAS pain scores before treatment. There was a trend for 
faster and more pain improvement using PCN treatment compared to PRF, but this 
difference failed to reach statistical significance nor did it reach a clinically 
important difference (mean reduction in VAS of > 30.0 mm).19 
Currently, most published studies on the effectiveness of either PCN or PRF are 
retrospective in nature, limited in the number of included patients, do not use a 
control group, and usually include only lumbar disk herniation patients. Although 
cervical disk herniation is not observed as often as lumbar disk herniation, it is an 
important cause of neck pain resulting in severe symptoms and disability.1 Patients 
with contained cervical disk herniation go through a variety of conservative 
treatments (eg, medication, fysiotherapy, manual therapy, epidural injection). Most 
of conservative treatments are not specific and take a longer time to recover and to 
regain quality of life. Surgical treatments range from cervical discectomy to artificial 
cervical disk replacement, or minimal invasive techniques such as PCN or PRF. 
Where discectomy or artificial disk replacement are more extensive, surgeries with 
consequently more adjacent risks are involved.20 Percutaneous techniques such as 
PCN or PRF, in theory, involve less risk for the patient. 
The advantage of PCN is that the procedure provides simple and efficient disk 
decompression with highly localized ablation causing minimal damage to 
surrounding tissue2,4,6 (Figure 6A,B). 
Similar to the results of Yang et al.,21 who in a retrospective study analyzed 171 
cervical disk herniation patients treated with either percutaneous cervical 
discectomy (97 cases), cervical PCN (50 cases), or a combination of these 2 
treatments (24 cases), we found no differences in clinical outcomes between the 
treatment modalities. Yang et al. concluded that each of the 3 interventions they 
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studied was clinically effective and that PCN was the least invasive treatment 
option, but that costs for PCN were high. Sim et al.,10 also in a retrospective study 
of cervical disk herniation patients (n = 22), concluded that PCN was safe and 
minimally invasive with excellent short-term clinical outcomes at 6 months which 
were similar to our 3-month results. 
A recent study by Cahana et al.13 reported that the biological effect of PRF was 
unlikely related to thermal damage, but that it was selectively targeting small 
diameter C and Ad nociceptive fibers. PRF should be considered nondestructive 
with very limited risk of (neurologic) complications. In a retrospective study, Yoon et 
al.22 analyzed the results of PRF treatment for cervicogenic discus pathology (n = 
22) and found a comparable improvement in pain scores (using a numeric rating 
scale) from baseline (mean NRS pain score 7) for up to 3 months after treatment 
(mean NRS score 2.5) as was observed in our study. In contrast to our results, 
they observed no complications related to PRF during the follow-up period. Chao et 
al.23 retrospectively included a 165 patients treated with PRF for cervical (n = 49) or 
lumbar radicular pain (n = 116) and concluded that PRF was a safe and useful 
treatment, with no complications reported. 
In our study, there were no differences in outcomes between PCN and PRF, 
indicating that both techniques can be considered equally effective. When 
choosing 1 treatment over the other, one should consider, for example, the 
complication risks, duration and treatment costs, the burden on the patient, and the 
experience of the treating physician with either of these procedures. Another 
consideration might be that PCN is a more causal treatment for discogenic 
herniation, as the herniation of the disk is retracted to the original space, where 
PRF is only symptomatic. Data on recurrence of symptoms are, however, 
unknown. Moreover, costeffectiveness concerning these treatments of cervical 
discogenic pain should be analyzed. 
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Figure 6. (A) Longitudinaal MRI of herniated disk at C5 to C6 level before percutaneous nucleoplasty 
(PCN) treatment. (B) Longitudinaal MRI of herniated disk at C5 to C6 level after PCN treatment. 
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Strengths and Limitations of this Study 
The limitation of this study is that it compares 2 active treatments rather than 1 
investigational treatment compared to placebo or usual care. Also, our follow-up 
was limited to 3 months. Strong points are the randomized study design, the use of 
2 rather less investigated treatments which are becoming more common in clinical 
practice and detailed data collection. To our knowledge, no previous clinical study 
compared PCN vs. PRF in a randomized controlled trial. 
Conclusion 
Pain symptoms improve similarly significant in patients with a contained, single-
level herniated cervical disk with both PCN and PRF treatment. Although PCN-
treated patients reported a trend for faster and more pain improvement compared 
to PRF, this difference failed to reach statistical significance or a clinically important 
difference. Other factors (complication risks, duration and treatment costs, burden 
on the patient, and experience of the treating physician) contribute to the 
decision to choose 1 treatment over the other. 
Acknowledgements  
The authors thank Yuen-Keek Sham for her assistance in data management. All 
authors played a role in study conception and design. W.H. and J.W. collected the 
study data. W.v.d.W. and W.H. analyzed the data and together with T.L. and K.V. 
interpreted the findings and drafted the article. All authors critically reviewed the 
article and improved the document where necessary. All authors approved the final 
article version. 
Disclosures 
The institution W. van der Weegen works for receives study grants from Cotera Inc. 
and ZimmerBiomet Inc. but these are unrelated to the current study. W. van der 
Weegen is also a consultant for ZimmerBiomet Inc. None of the others have any 
disclosures to report. 
  
A 
 100 
References 
1. Gangi A, Tsoumakidou G, Buy X, Cabral JF, Garnon J. Percutaneous 
techniques for cervical pain of discal origin. Semin Musculoskelet Radiol. 
2011;15:172–180. 
2. Cuellar VG, Cuellar JM, Vaccaro AR, Carragee EJ, Scuderi GJ. 
Accelerated degeneration after failed cervical and lumbar nucleoplasty. J 
Spinal Disord Tech. 2010;23:521–524. 
3. Van Zundert J, Patijn J, Kessels A, Lam_e I, van Suijlekom H, van Kleef M. 
Pulsed radiofrequency adjacent to the cervical dorsal root ganglion in 
chronic cervical radicular pain: a double blind sham controlled randomized 
clinical trial. Pain. 2007;127:173–182. 
4. Van Zundert J, Huntoon M, Patijn J, et al. 4. Cervical radicular pain. Pain 
Pract. 2010;10:1–17. 
5. Gebremariam L, Koes BW, Peul WC, Huisstede BM. Evaluation of 
treatment effectiveness for the herniated cervical disc: a systematic review. 
Spine (Phila Pa 1976). 2012;37: E109–E118. 
6. Gerszten PC, Welch WC, King JT. Quality of life assessment in patients 
undergoing nucleoplasty-based percutaneous discectomy. J Neurosurg 
Spine. 2006;4:36–42. 
7. Yan D, Li J, Zhu H, Zhang Z, Duan L. Percutaneous cervical nucleoplasty 
and percutaneous cervical discectomy treatments of the contained cervical 
disc herniation. Arch Orthop Trauma Surg. 2010;130:1371–1376. 
8. van Kleef M, Spaans F, Dingemans W, Barendse GA, Floor E, Sluijter ME. 
Effects and side effects of a percutaneous thermal lesion of the dorsal root 
ganglion in patients with cervical pain syndrome. Pain. 1993;52:49–53. 
9. Li J, Yan DL, Zhang ZH. Percutaneous cervical nucleoplasty in the 
treatment of cervical disc herniation. Eur Spine J. 2008;17:1664–1669. 
10. Sim SE, Ko ES, Kim DK, Kim HK, Kim YC, Shin HY. The results of cervical 
nucleoplasty in patients with cervical disc disorder: a retrospective clinical 
study of 22 patients. Korean J Pain. 2011;24:36–43. 
11. Birnbaum K. Percutaneous cervical disc decompression. Surg Radiol Anat. 
2009;31:379–387. 
12. Halim W, Wullems JA, Lim T, et al. The long-term efficacy and safety of 
percutaneous cervical nucleoplasty in patients with a contained herniated 
disk. Pain Pract. 2013;13:364–371. 
13. Cahana A, Van Zundert J, Macrea L, van Kleef M, Sluijter M. Pulsed 
radiofrequency: current clinical and biological literature available. Pain 
Med. 2006;7:411–423. 
14. Chua NHL, Vissers KC, Sluijter ME. Pulsed radiofrequency treatment in 
interventional pain management: mechanisms and potential indications – a 
review. Acta Neurochir (Wien). 011;153:763–771. 
15. Van Boxem K, Cheng J, Patijn J, et al. 11. Lumbosacral radicular pain. 
Pain Pract. 2010;10:339–358. 
16. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity 
scale: what is moderate pain in millimetres? Pain. 1997;72:95–97. 
17. Vernon H, Mior S. The Neck Disability Index: a study of reliability and 
validity. J Manipulative Physiol Ther. 1991;14:409–415. 
101 
18. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and 
norming of the Dutch language version of the SF-36 Health Survey in 
community and chronic disease populations. J Clin Epidemiol. 
1998;51:1055–1068.  
19. Lee JS, Hobden E, Stiell IG, Wells GA. Clinically important change in the 
visual analog scale after adequate pain control. Acad Emerg Med. 
2003;10:1128–1130. 
20. Zhong Z-M, Zhu S-Y, Zhuang J-S, Wu Q, Chen J-T. Reoperation after 
cervical disc arthroplasty versus anterior cervical discectomy and fusion: a 
meta-analysis. Clin Orthop Relat Res. 2016;474:1307–1316. 
21. Yang B, Xie J, Yin B, Wang L, Fang S, Wan S. Treatment of cervical disc 
herniation through percutaneous minimally invasive techniques. Eur Spine 
J. 2014;23:382–388. 
22. Yoon YM, Han SR, Lee SJ, Choi CY, Sohn MJ, Lee CH. The efficacy of 
pulsed radiofrequency treatment of cervical radicular pain patients. Korean 
J Spine. 2014; 11:109–112. 
23. Chao S-C, Lee H-T, Kao T-H, et al. Percutaneous pulsed radiofrequency in 
the treatment of cervical and lumbar radicular pain. Surg Neurol. 
2008;70:59–65.
 
  
 102 
  
 Chapter 8 
 
GENERAL DISCUSSION
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It is widely accepted that chronic pain reduces quality of life, leads to depression, 
work absenteeism and inability to participate in activities of daily live. But chronic 
pain is often not considered as a “stand-alone” disease, and consequently receives 
less attention from policymakers. As a result, clinical research on chronic pain and 
its’ treatment are less developed compared to other medical specialities. Hence, I 
started this thesis project. Chronic pain is not only a medical problem but even 
more a social problem, imposing a huge burden on society. The costs involved of 
the medical treatments alone, runs into the hundreds of millions, while the damage 
in the social field, particularly in the form of absenteeism, amounts to billions of 
euros and dollars. The International Working Group for chronic pain strongly 
recommends on improved training and education within all health care curricula1, 
and also the need for more and better clinical research on the topic of chronic pain 
is obvious. Clinical research within pain medicine is an emerging field but 
considering the importance and impact of chronic pain for both patients and 
society, there is an important and immediate need for high quality clinical research 
to relieve this burden by developing and improving chronic pain treatments which 
are both highly effective, safe and cost-effective, resulting in clear evidence. The 
aim of this thesis was to analyse the clinical effectiveness and safety of minimal 
invasive interventional techniques in patients with head and neck pain. First, a 
retrospective analysis of treatment results was done, followed by prospective and 
randomized clinical trials. My findings are as follows: 
 
1. The application of pulsed radiofrequency to the atlanto-axial joint is a safe 
and effective technique in patients with cervicogenic headache (CEH) who 
are non-responsive to conservative treatment. 
I found that pulsed radiofrequency for atlanto-axial joint had a longer duration in 
efficacy (>50% pain relief at 2 months, 6 months and 1 year) in 50% of all patients 
at 2 months (43/86), at 6 months (43/86) and in 44.2% of all patients after one year 
(38/86), compared with intra-articular atlanto-axial steroid injections.2 Intra-articular 
injection of steroids is a frequently used procedure, but the duration of the effect of 
these injections is limited and there may be deleterious side effects if they are 
repeated too often.3,4 Also, the potential fatal risk involved with injecting steroids in 
the atlanto-axial joint should not be underestimated. The atlanto-axial joint may be 
a possible source of pain in cervicogenic headache but the scientific evidence on 
applying pulsed radiofrequency to the atlanto-axial joint is scarce. Sluijter et al. 
published a case report (n=6) using this treatment and reported good results after 1 
year.5 Although the limitation of our study is its’ retrospective design, our data was 
prospectively collected from ongoing general clinical practice and included a large 
number of patients (n=86). I concluded that further prospective trials are required to 
validate our findings and that this technique should be considered earlier in the 
course of the disease in view of its long-term efficacy. However, this technique 
should be reserved for highly skilled pain specialists. Further research should focus 
on improving the diagnostic process, on optimizing CEH patient selection criteria 
for PRF treatment and on improving technical specifications (i.e. pulse duration, 
pulse frequency) of PRF treatment for these patients. 
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2. The application of pulsed radiofrequency of the atlanto-axial joint is a safe 
and effective technique in patients with whiplash related symptoms. 
 
I retrospectively explored the efficacy of the atlanto-axial joint pulsed 
radiofrequency treatment in whiplash patients (n=45). Not only the common 
symptoms in whiplash patients (i.e. headache, neck pain, fatigue) showed a 
significant improvement but also the cognitive disturbances caused by whiplash 
such as memory deficit, sleep and concentration disturbances improved. 
Significantly higher health-related quality of life in terms of bodily pain (p<0.05) and 
health change (p<0.01) on the SF-36 were observed in our study.6 A previous 
study also observed a significant improvement of whiplash related symptoms with 
PRF treatment of the cervical medial branch only (64.3% of patients with significant 
pain improvement 9 months after treatment).7 In our study we compared patient 
characteristics between responders and non-responders. However, we were 
unable to detect differences in baseline demographics (i.e. pain before treatment, 
duration of symptoms) between these two groups. In a more recent study Smith et 
al. concluded that treating pain in whiplash patients, using conventional neurotomy, 
was very important for improving the psychological status of these patients8, which 
is in concordance with our results. Due to the limiting factors of our retrospective 
study, pulsed radiofrequency treatment of atlanto-axial joints can only be tentatively 
viewed as a promising treatment modality for whiplash patients with CEH and 
should be subject to validation in future prospective studies. Preferably, these 
studies should use a randomized trial design, comparing pulsed radiofrequency 
versus standard care and with sufficient follow up duration, preferably one year. 
One should then also consider using multiple trial arms that include different 
duration of pulsed radiofrequency treatment. 
 
3. Pulsed radiofrequency treatment of the gasser ganglion is effective in the 
treatment of specific Trigeminal neuralgia. 
In this retrospective study, I explored the effect of percutaneous pulsed 
radiofrequency treatment of the Ganglion of Gasser in patients with specific 
trigeminal neuralgia (n=36). All recent patients with typical trigeminal neuralgia 
from a second level pain center were contacted for a telephonic and medical record 
evaluation for their current state of pain and the post-procedural data after pulsed 
radiofrequency treatment of the trigeminal ganglion at 2, 6, and 12 months.9 In this 
study all patients received percutaneous pulsed radiofrequency treatment of the 
gasser ganglion with a duration of 6 to 10 minutes. Most patients experienced 
excellent pain relief (>80%) at 2, 6, and 12 months (73.5% (25/34), 61.8% (21/34), 
and 55.9% (19/34)), without complications observed. This result is an 
encouragement to apply pulsed radiofrequency treatment of the gasser ganglion as 
an alternative treatment method for trigeminal neuralgia based on: (1) excellent 
pain relief observed up to one year after treatment; (2) the absence of side effects 
or complication; (3) pulsed radiofrequency can be used repeatedly without fear for 
anesthesia dolorosa; (4) pulsed radiofrequency can be also be applied for atypical 
trigeminal neuralgia, and (5) the first branch of nerve trigeminus can be treated with 
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pulsed radiofrequency without the effects of corneal lesion. In contrast, some 
studies showed that pulsed radiofrequency was not effective in trigeminal 
neuralgia.10,11 However, these studies used a 2 minutes duration of pulsed 
radiofrequency rather than 6-10 minutes used in our study. Therefore, further 
investigations using a prospective study design in specific trigeminal neuralgia 
patients are recommended to evaluate for better efficacy and evidence by 
exploring the different stimulation modalities, durations and parameters of pulsed 
radiofrequency. 
 
4. Percutaneous Cervical Nucleoplasty is a safe and effective treatment in 
patients with cervical discogenic pain due to a contained disc herniation. 
In a retrospective study, I explored the long-term efficacy and safety of PCN, and 
the influence of optimal selection criteria in a secondary line pain treatment facility. 
A total of 27 patients treated with PCN fulfilling the selection criteria (Group A) were 
studied and compared to 42 patients not meeting these specific criteria (Group B). 
Selection criteria were the number of cervical levels involved, any concomitant 
cervical spine pathology and possible previous neck surgery. Outcomes were 
assessed using the Visual Analogue Scale (VAS) and a four-level Likert item for 
perceived pain and satisfaction, the Neck Disability Index (NDI), and the Short 
Form 36 (SF-36). Additional relevant clinical outcomes were retrieved from medical 
records. The following results were observed: The postoperative mean VAS pain 
for Group A was 29.9 (SD ± 32.6) at a mean follow-up of 24 months (range: 2–45). 
Only 10% of these patients reported mild transient adverse events. There was a 
trend, but no significant difference between both groups in pain scores. However, 
treatment satisfaction was higher for Group A (74.1 ± 27.2–55.5 ± 31.4, P = 0.02). 
Group A also reported better physical functioning based on the Physical 
Component Summary (43.6 ± 10.6–37.3 ± 12.0, P = 0.03) and showed a larger 
proportion of patients no longer using any medication post treatment (63–26%, P = 
0.01).12 Our results are in line with the findings of Li and Yan. Li et al. evaluated the 
prospective results of 126 PCN procedures for contained cervical disc herniation at 
2 weeks, 1, 3, 6 and 12-month follow up. The VAS pain scores improved 
statistically (p< 0.01) for all follow up moments (range 2.42 ±0.71 to 2.44 ± 0.71) 
compared with pre-treatment findings (7.25 ± 0.44).14 The rate of excellent and 
good results based on the modified Macnab criteria was 81.7%. Besides a 
technical complication (broken device tip) which was of no further consequence, no 
complications were reported. This study shows PCN to be safe and effective at 
short-, mid-, and long-term FU. Yan et al. retrospectively compared clinical out- 
comes of 176 patients with symptomatic contained cervical disc herniation treated 
with PCN (n = 81) or percutaneous cervical discectomy (PCD) (n=95) at a FU of 
16–48 months.13 In the PCN group, the VAS pain score improved from 7.12 ± 1.13 
to 2.74 ± 0.89 (P < 0.001) compared with 7.18 ± 1.09 to 2.71 ± 0.91 (P< 0.001) in 
the PCD group. There was no difference found in success rates (Modified Macnab 
criteria scoring excellent or good) between both groups, respectively, 77.8% (PCN) 
and 79.5% (PCD). One case of discitis was reported within the PCD group. The 
results show that both methods are safe and have good long-term clinical 
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outcomes. This study was of high methodological quality. Hence, overviewing this 
evidence, percutaneous cervical nucleoplasty (PCN) is a safe and effective 
treatment in symptomatic patients with contained cervical herniated discs. It 
provides simple and efficient disc decompression, using a controlled and highly 
localized ablation, but evidence regarding long-term efficacy is limited. The above 
presented results show long-term effectiveness and safety of PCN in patients with 
a one-level contained cervical herniated disc, on the condition that patients are 
carefully selected, meeting ideal criteria for successful PCN. For the future, these 
findings must be confirmed in prospective studies including further exploring of 
multi-level pathology. 
 
5. A systematic review of the literature demonstrated moderate evidence for 
effectiveness of percutaneous nucleoplasty. 
 
We performed a systematic review of the published literature on cervical 
nucleoplasty and found that the number of published studies was very low and the 
quality of the available studies was only moderate.15 We were able to include 10 
articles (3 RCTs and 7 nonrandomized studies) which represented a total of 1021 
patients. Of these, 823 patients (≥ 892 discs) were treated by PCN and the 
remaining patients were controls who were treated with either conservative care or 
percutaneous cervical discectomy (PCD). All studies showed low methodological 
quality, except for two. The level of evidence of the RCTs was graded as moderate, 
with low to moderate applicability and clinical relevance according to these RCTs. 
This was mainly due to a poorly description of the study population, control 
intervention, co-interventions, outcome measures, and specific analysis 
methodologies. Future randomized RCTs on cervical PCN should aim to increase 
their methodological quality and identify criteria to improve outcome(s). 
 
6. Percutaneous Cervical Nucleoplasty and Pulsed Radiofrequency are 
equally effective in patients with cervical neck pain.  
 
In a prospective randomized clinical trial, I found that PCN and PRF are equally 
effective for treating cervical pain caused by a contained single level cervical 
herniated disc.16 Cervical neck pain is often caused by cervical disc pathology and 
hence results in suffering and disability in the adult population. Surgeons as well as 
patients are increasingly aware of post-surgery-related complications.17 This 
stimulated the clinical usage of minimal-invasive treatments such as Percutaneous 
Nucleoplasty (PCN) and Pulsed Radiofrequency (PRF). However, scientific 
evidence on both treatments is limited. Therefore, we evaluated the efficacy of 
PCN compared to PRF in patients with contained cervical disc herniation in a 
prospective randomized clinical trial including 34 patients with radicular pain due to 
a single contained cervical disc herniation, treated with either Percutaneous 
Cervical Nucleoplasty or Pulsed Radio Frequency.16 Demographic data was 
collected and patients completed the Medical Outcomes Study 12-Item Short Form 
(SF-12) Health Survey, visual analog scale (VAS) and the Neck Disability Index 
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(NDI) 1, 2 and 3 months after treatment. My findings showed that in the 
Percutaneous Cervical Nucleoplasty group (n=17, mean age 52.4 years, 10 
female/7 male) patients were treated at C5-C6 (8 cases) or C6-C7 (9 cases). In the 
Pulsed Radiofrequency group (n=17, mean age 49.5 years, 8 female/9 male) 
patients were treated at C3-C4 (1 case), C5-C6 (10 cases) or C6-C7 (6 cases). At 
three months, mean pain VAS improved significantly from baseline in the 
Percutaneous Cervical Nucleoplasty group (mean improvement: 43.4 points) and in 
the Pulsed Radiofrequency group (34.0 points). However, improvement in one 
group was not superior compared to the other group (p=0.48). No serious 
complications were reported. Within three months, both PCN and PRF show 
significant pain improvement in patients with contained cervical disc herniation, but 
none was superior to the other. Both treatment options appear to be effective and 
safe in regular clinical practice. Comparing these two interventional techniques 
towards placebo treatment is not possible in normal clinical practice and research. 
Further research should focus on optimizing the outcome measures at the long-
term for these treatments in patients with difficult to treat cervical neck pain. Strict 
recommendations on specific selection and inclusion criteria will further improve 
outcome and limit complications.  
  
General discussion and recommendations  
Usually patients with cervical pathology are treated with a variety of conservative 
treatments (e.g., medication, physiotherapy, manual therapy, epidural injection) 
which are not very specific, have often low evidence and take a long time to result 
in a clinical effect including improvement of the quality of life of the individual 
patient. Surgical treatments, ranging from cervical discectomy to artificial cervical 
disc replacement are considered if conservative treatments fails but are usually 
quite invasive with consequently more adjacent risks involved without promising 
optimal clinical outcome. Minimal invasive pain treatments using percutaneous 
techniques such as cervical nucleoplasty or pulsed radiofrequency involve, in 
theory, less risk compared to surgical interventions but hold the promise of being 
more effective than conservative treatment modalities. Unfortunately the clinical 
evidence behind minimal invasive pain treatments is still rather limited, and 
deserves much more attention and research in order to define a more eloquent 
treatment algorithm for patients with chronic cervical disorders. To build up this 
evidence, we formulate specific recommendations based on the scientific work 
presented in this thesis. 
 
Recommendations for clinical practice: 
1. Pulsed radiofrequency is equally effective in the treatment of cervical neck pain 
when applied to the dorsal ganglion in comparison with conventional 
radiofrequency and therefore should be preferred because of the minimal side 
effects described. 
2. Pulsed radiofrequency treatment is effective in the treatments of upper cervical 
joint pain (C1-C2) and should be more strongly recommended than intra-
articular or per-neural steroid injections. 
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3. Pulsed radiofrequency is a good alternative for the minimal invasive treatment 
of trigeminal neuralgia compared to radiofrequency treatment, since it now has 
been proven to be a safe and effective method for this medical condition. 
4. Pulsed radiofrequency can be used repeatedly for patients with different 
cervical spine pathologies including herniated disc, whiplash associated 
disorders and trigeminal neuralgia because of the low risk of complications. 
5. Pulsed Radiofrequency and Percutaneous Cervical Nucleoplasty both can be 
used in patients with contained cervical disc herniation since they are equally 
effective. 
6. Percutaneous Cervical Nucleoplasty has on a theoretical basis potentially more 
risks for complications than pulsed radiofrequency in the treatment of cervical 
disc hernia. 
7. Percutaneous Cervical Nucleoplasty must be applied in a sterile conditions in a 
fully equipped operation room and can only be performed by a trained and 
skilled pain specialist who completed this FIPP examination or any other equal 
accreditation system. 
 
Recommendations for future research:  
The impact of chronic pain in quality of life is underestimated and has in all 
dimensions a worse score than in other chronic conditions. For example, the 
decrease in quality of life is similar to that of patients with chronic heart failure. 
Especially in combination with another chronic disease, chronic pain (i.e. back 
pain, headache) can have a larger than expected negative impact on the self-rated 
health of the patient. Demyttenaere et al. described that chronic pain patients 
suffer more from depression, generalized anxiety, agoraphobia or panic disorder, 
social anxiety disorder, post-traumatic stress, alcoholism and addiction compared 
to the normal population.18 These facts combined with the high incidence and 
prevalence of chronic pain, the wide variety in treatment, and that a relatively large 
number of patients experienced their treatment for chronic pain as inadequate, 
signifies the importance of high quality research in this field. Chronic pain not only 
has a significant impact on quality of life, Activities of Daily Living (ADL), mood, sick 
leave but is also accompanied by considerable direct and indirect costs. Recent 
epidemiologic data have shown significant gaps in data and limited quality of 
published studies. Moreover, specific research methodologies used in 
pharmacological research are not always possible like blinding and using placebo 
treatments in minimal invasive and surgical pain treatment techniques. Hence, 
specific trial adaptations and new research modalities are highly needed to build 
growing and new evidence in head and neck pain syndromes.  
Recommendations for further research: 
1. Increase awareness that prospective randomized trials and outcome 
studies are needed to build further evidence for minimal invasive treatment 
modalities. 
2. Develop clear definitions and a pain classification system to categorize 
more specifically patient populations that further support research into 
epidemiology and pathophysiology.  
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3. Improve knowledge and expertise of pain diagnostics and interventions; 
include training on chronic pain in the curricula of all medical training 
courses and develop standards for quality care and outcomes. 
Epidemiological research helps to raise awareness of these problems and 
can give direction to future areas of research to improve the pain medicine. 
4. Make collaborative initiatives in research between second line pain centers 
and specific academic research centers to offer optimal high through-put 
research possibilities in common pain syndromes. 
5. Make the need for high quality pain research visible on the national 
research agenda. 
Recommendations for education: 
None of the diagnostic tests and minimal invasive interventional techniques should 
be performed without proper high level specialized training and education, 
including FIPP examination. Therefore:  
1. Increase awareness that good education and training is needed to avoid 
unwanted effects and complications. 
2. Increase general knowledge and expertise about correct diagnosing and 
treating patients with chronic pain. 
3. Educate medical professionals in adequate referring patients with chronic pain 
to the appropriate medical specialist and treatment program. 
4. Medical specialists performing minimal invasive interventional procedures 
should be highly skilled and trained including an evaluation by e.g. a FIPP 
examination learning about the evidence, the indications, the limitations, 
adverse effects and complications of each technique. 
5. Educate all medical professionals in standardized quality outcome measures. 
In general, nowadays participating in our high demanding modern society has 
never been more important. The reduced quality of life due to chronic pain is one of 
the major factors which can people limit to participate fully in our society. This is 
undesirable and the reason people are looking for solutions. Patients nowadays 
look further than their known medical specialist and proposed treatments. This is a 
positive effect and that is why informing our medical colleagues and patients about 
new medical pain treatments is an important task for us as pain doctors. Due to 
recent developments in pain practice treatments we have the luxury to have new 
modern efficient treatments. Especially comparing to older traditional treatments, 
we can now offer one day pain treatments where patients are able to return home 
immediately afterwards. This reduces medical costs and allows patients to go to 
work faster. Post-treatment complications of more invasive treatments can be 
significantly reduced. The economic benefits are evident, not only the medical cost 
but also the faster reintegration into the participation of their work. Hence it is 
important to have clear guidelines and treatment algorithms, not only for medical 
professionals but also for the patients. This awareness in both groups is important 
to further exploration new pain treatments. Research and development of the pain 
field is important for the future and the acceptance of these new pain treatment 
methods based on the best scientific evidence.
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 Chapter 9 
 
SUMMARY
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The aim of this thesis research was to investigate the efficacy of pulsed 
radiofrequency and percutaneous nucleoplasty in patients with chronic pain. 
 
In Chapter 1 we provide an overview of the definition, epidemiology and the impact 
of chronic pain. The distinction was made between acute and chronic pain and 
between nociceptive and neuropathic pain, diagnostics and treatment. We 
discussed the two kinds of treatments (conservative and interventional), each with 
their risk and benefits. 
 
In Chapter 2 we investigated the efficacy of pulsed radiofrequency treatment in 
atlanto-axial joint. In this retrospective study, data was collected from one single 
pain center in ongoing clinical pain practice. We concluded that Pulsed 
Radiofrequency (PRF) application of the lateral atlanto-axial joint is a feasible and 
safe technique in patients with cervicogenic headache who are nonresponsive to 
other techniques, and that it had a longer term efficacy than atlanto-axial intra-
articular steroid injection. 
 
In chapter 3 we found that lateral atlanto-axial joint pulsed radiofrequency 
treatment in  whiplash patients with cervicogenic headache improved not only the 
pain, but also improved cognitive disturbance and fatigue.  
 
In chapter 4 we looked for evidence on pulsed radiofrequency treatment in 
trigeminal neuralgia. Yes, we found the evidence. We concluded that PRF is also 
effective in Trigeminal Neuralgia if the duration of the radio frequency takes 6-10 
minutes rather than 2 minutes! PRF of the trigeminal ganglion should be further 
evaluated as an alternative treatment method for Trigeminal Neuralgia. 
 
In chapter 5  we evaluated the long term effectiviness of Percutaneous Cervical 
Nucleoplasty (PCN) in patients with a one-level contained cervical herniated disk. 
We also studied the importance of selecting patients meeting ideal criteria for 
successful PCN. We confirmed in this retrospective study that PCN is effective with 
long term follow up and also safe to use. Using ideal criteria for successful PCN 
proved to be important. 
 
In chapter 6 we systematically reviewed current evidence on percutaneous 
nucleoplasty for cervical herniated disk.  All included studies showed PCN to be an 
effective and safe procedure in the treatment of (contained) herniated disc at short- 
mid-, and long-term follow-up. However, the level of evidence was moderate and 
showed only low to moderate applicability and clinical relevance.  
In chapter 7 we compared two active methods (percutaneous cervical nucleoplasty 
versus pulsed radiofrequency of dorsal root ganglion) in treatment of patients with 
contained cervical disc herniation. After completing this randomized clinical trial we 
concluded that both PCN and PRF show a significant improvement in pain, but 
none proved superior to the other. Both treatment options appear to be effective 
and safe in regular clinical practice.
 
 
Chapter 10 
 
NEDERLANDSE SAMENVATTING
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Het doel van dit proefschrift was om de werkzaamheid van gepulseerde 
radiofrequentie en percutane nucleoplasty bij patiënten met chronische pijn te 
onderzoeken. 
In hoofdstuk 1 geven we een overzicht van de definitie, epidemiologie, de impact 
van chronische pijn, het onderscheid tussen acute en chronische pijn en tussen 
nociceptieve en neuropathische pijn, diagnostiek en behandeling. We bespraken 
verder in dit proefschrift de twee soorten van behandeling met hun risico's en 
voordelen. 
In hoofdstuk 2 onderzochten we de effectiviteit van “pulsed radiofrequentie” 
behandelmethode in het atlanto-axiale gewricht. Dit was een retrospectieve studie 
en de gegevens werden verzameld uit één pijncentrum. De conclusie van deze 
studie: Pulsed radiofrequentie therapie (PRF) met een laterale atlanto-axiale 
benadering van het atlanto-axiale (AA) gewricht is een haalbare en veilige techniek 
bij patiënten met cervicogene  hoofdpijn die niet responsief zijn voor andere 
technieken en deze therapie heeft een langere termijn werkzaamheid dan atlanto-
axiale intra-articulaire steroïde injectie. 
In hoofdstuk 3 vonden we dat pulsed radiofrequentie therapie met een laterale 
atlanto-axiale benadering van het AA gewricht in whiplash patiënten met 
cervicogene hoofdpijn niet alleen de pijn verbeterde, maar ook de cognitieve 
stoornis en vermoeidheid. 
In hoofdstuk 4 in dit proefschrift onderzochten we de effectiviteit van PRF bij 
trigeminusneuralgie. Ja, we vonden het bewijs. Het percentage van de patiënten 
die een uitstekende verlichting van de pijn (> 80% pijnverlichting)  toonden na 2, 6 
en 12 maanden was 73.5% (25/34), 61.8% (21/34) en 55.9 % (19/34) 
respectievelijk. Het percentage patiënten met voldoende pijnverlichting (50-80% 
pijnverlichting) na  2, 6 en 12 maanden bedroeg 14.7% (5/34), 17.6% (6/34) en 
17.6% (6/34) respectievelijk. Er werden geen complicaties fo heropnames 
gerapporteerd. Conclusies: PRF is ook effectief in Trigeminusneuralgie wanneer de 
duur van de radiofrequentie 6-10 minuten bedraagt!  PRF van het trigeminale 
ganglion moet verder worden geëvalueerd als een alternatieve werkwijze voor 
trigeminusneuralgie behandeling. 
In hoofdstuk 5 onderzoeken we Percutane cervicale Nucleoplasty (PCN), de meest 
toegepaste techniek op het cervicale niveau met een laag risico op thermische 
schade. Verschillende gepubliceerde studies hebben aangetoond dat PCN veilig 
en effectief is. Hoewel deze behandelings-modaliteit is beschreven in de literatuur, 
was het beschikbare bewijs over de werkzaamheid niet voldoende om definitieve 
conclusies over de optimale therapie te maken. We bevestigden in deze 
retrospectieve studie de lange termijn effectiviteit en veiligheid van PCN bij 
patiënten met een cervicale hernia op één niveau. Daarnaast toonden we aan dat 
strikte selectie van patiënten aan de hand van duidelijke criteria tot een meer 
succesvolle PCN behandeling leid. 
In hoofdstuk 6 voerden we een systematische review uit van de huidige literatuur  
van percutane nucleoplasty als behandeling voor cervicale hernia. Alle 
geïncludeerde studies toonden aan dat PCN een effectieve en veilige procedure is  
voor de behandeling van cervicale hernia op korte, middellange en lange termijn 
follow-up. De bewijskracht is matig en toont slechts geringe tot matige 
toepasbaarheid en klinische relevantie. 
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In hoofdstuk 7 vergelijken we twee actieve therapieën: PCN versus PRF van de 
dorsale wortel ganglion bij patiënten met cervicale hernia. Het bewijs voor de 
effectiviteit van deze interventies, PCN en PRF van dorsale wortel ganglion is nog 
niet goed gedocumenteerd bij patiënten met cervicale hernia. We concluderen dat 
zowel PCN als PRF tot een significante verbetering van de pijnklachten leid bij 
patiënten met een cervicale hernia, maar geen van beide is superieur. Beide 
behandelingen lijken effectief en veilig in de reguliere klinische praktijk. Er is 
behoefte aan meer hoogwaardige RCT onderzoek met gebruik van gevalideerde 
uitkomstmaten naar de werkzaamheid en veiligheid van beide technieken. 
Bovendien moet de gezondheids-economische waarde met betrekking tot deze 
behandelingen van cervicale discogene pijn worden geanalyseerd.  
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